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APPENDIX 2-F
ABSTRACT

HIF-INDEPENDENT RESPONSES IN HYPOXIA

By Divya Padmanabha, Ph.D.

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2015.

Major director: Keith D. Baker, Ph.D, Assistant Professor, Biochemistry and Molecular
Biology

The adaptive response to hypoxia is accompanied by widespread transcriptional
changes that allow for prolonged survival in low oxygen. Many of these changes are
directly regulated by the conserved hypoxia-inducible factor-1 (HIF-1) complex;
however, even in its absence, many oxygen-sensitive transcripts in Caenorhabditis
elegans are appropriately regulated in hypoxia. To identify mediators of these non-HIFdependent responses, I established a hif-1 mutant reporter line that expresses GFP in
hypoxia or when worms are treated with the hypoxia mimetic cobalt chloride (cobalt
chloride). The reporter is selective and HIF-independent, in that it remains insensitive to
a number of cellular stresses, but is unaffected by mutation of the prolyl hydroxylase
egl-9, suggesting that the regulators of this response pathway are different from those
ix

x
controlling the HIF pathway. I used the HIF-independent reporter to screen a
transcription factor RNAi library and identified genes that are required for hypoxia
sensitive and cobalt chloride-induced GFP expression. Three mediators of the HIFindependent response zinc finger protein BLMP-1, chromatin remodeling factor LIN-40,
and T-box transcription factor TBX-38 were isolated as mediators of the HIFindependent response. First, we show that mutation of blmp-1 renders animals sensitive
to hypoxic exposure and that blmp-1 it is required for appropriate hypoxic-induced
expression of HIF-independent transcripts. Further, we demonstrate that BLMP-1 is
necessary for an increase of hypoxia-dependent histone acetylation within the promoter
of a non-HIF-dependent hypoxia response gene. Additionally, we explore BLMP-1’s role
in two hypoxia-regulated physiological processes namely unfolded protein response and
collagen formation. We also briefly investigate the role of LIN-40 in the hypoxia
response.

x
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General introduction and thesis organization
Oxygen homeostasis is one of the most fundamental physiological processes necessary
for aerobic animals. All metazoans utilize molecular oxygen to generate metabolic
energy for normal growth and for maintaining intracellular bioenergetics including
oxidative phosphorylation. During evolution, multicellular organisms have developed
complex networks for oxygen homeostasis at both systemic and cellular levels
(Semenza, 2014). The condition when cellular oxygen levels do not meet the
physiological demand is termed as hypoxia, and it occurs at oxygen concentrations
below <2%. Hypoxia occurs during development, homeostasis, as well as many
pathological conditions, such as cancer, ischemia, and stroke. In humans, systemic,
local, and intracellular homeostatic responses are triggered in response to hypoxia in
conditions like anemia owing to the reduced oxygen carrying capacity of blood, high
altitude-related low oxygen partial pressure in arterial blood, neovascularization in
ischemic myocardium, and pulmonary disease, or in toxin-mediated oxygen limitation
(Iyer et al., 1998; Semenza, 2003). Hypoxia dependent responses have been largely
studied with respect to the tumor microenvironment, owing to its irregular vascular
supply and altered metabolic and proliferative status (Dewhirst, Cao, & Moeller, 2008).
Laboratory and clinical evidence strongly associate hypoxia with tumor development
and the hypoxia phenotype is strongly associated with adaptive responses such as
decreased proliferation and protein synthesis, high rates of glycolysis and anaerobic
metabolism, increased secretion of angiogenic factors, increased metastatic potential,
and poor response to therapy (Wouters & Koritzinsky, 2008). Given the importance of
hypoxia related responses, we sought to isolate new mediators of this response.

2
First, I give an introduction to hypoxia mediated cellular changes with an emphasis on
the function of Hypoxia Inducible Factor, the most widely studied effector of hypoxia
responses. Although my thesis examines HIF-independent factors, understanding the
regulation of HIF-1 is critical. Owing to the pervasive nature of HIF-1, it is highly likely
that HIF-1 and the HIF-independent regulator-BLMP1 in this study-work synergistically
or antagonistically to orchestrate the hypoxia pathways. It is also possible that the
oxygen sensors that mediate the HIF-1 response also mediate the HIF-independent
response. Next, I introduce the hypoxia adaptation pathway in C.elegans and highlight
some differences in the regulation of hypoxia in the worm. I then try to summarize the
current literature on HIF-independent processes in an effort to highlight that a lot is
unknown with respect to hypoxia mediated molecules.
In the results, I elaborate on the details of the RNAi screen conducted to identify the
HIF-independent molecule. There is also a section on the construction of C.elegans
hypoxia chamber. I then describe the identification and role of BLMP-1 in hypoxia, its
downstream targets, and its importance for survival in hypoxia. I also try to understand
how BLMP-1 is regulated and its physiological role in hypoxia.
Apart from the BLMP-1 story, I also worked on a short study in alternative fat oxidation
pathways in Drosophila. The results from this shorty study are very interesting and they
lay the foundation to a novel aspect of long chain fatty acid oxidation.
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1. Introduction
1.1 History of hypoxia studies
The beginning of hypoxia studies was as early as 100 years ago when Schwarz and
colleagues noticed that normal mammalian cells under hypoxia were less sensitive to
irradiation than those irradiated in the presence of oxygen (Bertout, Patel, & Simon,
2008). A cytological evaluation of damage in patient tumors after radiation revealed that
patients allowed to breathe hyperbaric oxygen at 3 atmospheres pressure showed
better prognosis than patients allowed to break room air (Mcewen, 1965). Numerous
other studies evaluated the effects of hypoxia on transplanted or spontaneous tumor
regression after irradiation in mice and established that human tumors contained
radioresitant hypoxic cells. During the 1990s, it was found that hypoxic cells could be
targeted directly with hypoxia-specific cytotoxins, and a combination of radiation with a
hypoxia-specific cytotoxin would thus have the potential to destroy the entire tumor
(Michael Hockel, 2001).
Thereafter, the expression of a number of genes, including glucose-regulated proteins
and O2-regulated proteins such as heme oxygenase and erythropoietin, was found to
be oxygen dependent (Roll, Murphy, Laderoute, Sutherland, & Smith, 1991). Several
studies then explored the role of hypoxia in key physiological processes, including
angiogenesis (Hoeben et al., 2004), DNA replication (Young, Marshall, & Hill, 1988),
and metastasis (Brenk, Moore, Sharpington, & Orton, 1972) However, the mechanisms
by which gene transcription was regulated by hypoxia was not elucidated until the
discovery of HIFs in the 1990s.
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1.2 Hypoxia-inducible factor
1.2.1 Discovery of HIF-1
Systematic characterization of erythropoietin (EPO) by multiple groups led to the
identification of a cis-acting hypoxia response element (HRE) (5’-G/ACGTG-3’) in the 3’
flanking region of this locus that confers O2 regulation of EPO expression. Hypoxia
inducible factor (HIF-1) was subsequently described as a hypoxia-dependent
transcription factor that binds to EPO HRE and activates EPO transcript in hypoxic cells
(G. L. Wang, Jiang, Rue, & Semenza, 1995). This was followed by the purification of
HIF-1 and it was discovered that HIF-1 is a heterodimeric transcription factor composed
of an α and a β subunit. Both subunits are members of the basic helix-loop-helix (bHLH)
transcription factor family that contains a PAS domain, which was initially characterized
using the Drosophila proteins PER and SIM and the mammalian protein aryl
hydrocarbon nuclear translocator (ARNT) (FIGURE 1.1). While HIF-1β subunit is
generally expressed, the stability of HIF-1α subunit is tightly controlled by cellular
oxygen level (Jiang, Guo, & Powell-Coffman, 2001).

Figure 1.1: Protein domains of HIF-1α and HIF-1β. Functional domains and binding
domains are shown, bHLH, basic helix-loop-helix; ODD, oxygen-dependent degradation
domain; TAD and CTAD, N- and C-terminal transactivation domain; NLS, nuclear localization
signal; PAS, Per-ARNT-Sim.
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The dimeric HIF-1 complex binds to conserved HREs associated with numerous
transcriptional target genes. More than 100 genes are shown to be putative HIF-1 target
genes in mammals. The HIF-1 target genes encode protein products which are involved
in angiogenesis/vascular remodeling, energy metabolism, erythropoiesis, cell
proliferation and viability, which makes HIF-1 a major mediator of physiological and
pathophysiological responses to hypoxia. (Iyer et al., 1998; Wouters & Koritzinsky,
2008).
hif-1α -/- mice die by E10.5 with severe vascular defects, underscoring the essential role
of HIF-1 in controlling the embryonic responses to variations in oxygen concentrations
in the microenvironment (Ryan, Lo, & Johnson, 1998). The significance of the
transcriptional changes regulated by HIF-1 is highlighted by its role in cancer
progression (Giaccia, Siim, & Johnson, 2003; Semenza, 2003). HIF-1 accumulates in a
broad array of human cancers (Maxwell, Pugh, & Ratcliffe, 2001). HIF-1 accumulation
has been associated with poor prognosis in breast cancer, cervical cancer, ovarian
cancer, and neuroblastoma (Semenza, 2014). Some of the promising interventions for
anti-cancer therapies involve mechanism for downregulating HIF-1, either by inhibiting
translation or promoting degradation, or inhibiting key HIF target genes, such as VEGFA
(Giaccia et al., 2003).
The complexity of HIF-1 arises with the discovery of the HIF-1α paralogues. HIF-2α
(also known as endothelial PAS domain protein 1) is also oxygen-regulated and can
dimerize with HIF-1β to mediate hypoxia responses. While HIF-1α is expressed
ubiquitously, both HIF-2α and HIF-3α are expressed in more restricted, but partially
overlapping, cell types. HIF-1α and HIF-2α activate transcription of an overlapping but
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distinct set of genes (M. Wang et al., 2005). Another paralogue, HIF-3α inhibits the
transcriptional activity of HIF-1α by competing with HIF-1β (Makino Y et al. 2001)
1.2.2 REGULATION OF HIF-1
The discovery of prolyl hydroxylases is a great example for the utility of C. elegans in
dismantling the mechanism of HIF regulation. After the molecular characterization of the
HIF1 complex in mammals, the HIF1α subunit was found to be ubiquitinated and
degraded in normoxia by von Hippel-Lindau tumor suppressor (VHL). Using C.elegans,
egl-9 or prolyl hydroxylase (PHD) was found to hydroxylate specific proline residues on
the oxygen-dependent-degradation (ODD) of the HIF-1α subunit (Epstein et al., 2001).
Using oxygen and 2-oxoglutarate as co-substrate, iron and ascorbate as cofactors,
PHDs sense the intracellular oxygen tension as well as aerobic metabolites to regulate
the degradation of HIF-1α subunit (Figure 1.2).

Figure 1.2: Regulation of HIF-1 is tightly controlled by PHD and VHL-1. Details in the text.
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HIF-1/PHD/pVHL forms an evolutionarily conserved negative feedback loop to regulate
oxygen homeostasis. Interestingly, in C.elegans, expression of egl-9 mRNA was found
to be induced by hypoxia in a HIF-1-dependent manner (C. Shen, Nettleton, Jiang, Kim,
& Powell-Coffman, 2005). Mammalian PHDs also contain hypoxia response elements
and are induced by HIF-1 during hypoxia (N. Chen et al., 2011).
The regulation of HIF also occurs at levels independent of HIFα stability. Factor
inhibiting HIF (FIH) mediates hydroxylation of an asparagines residue in the carboxyterminal of the HIFα subunit, which blocks its interaction with transcription co-activator
p300 (C/EBP), thereby attenuating HIF-1 transcriptional activity (Mahon, Hirota, &
Semenza, 2001). FIH is also an iron and 2-oxoglutarate dependent dioxygenase and
could function as the oxygen sensor. Moreover, PHD regulates HIF-1 activity in a VHLindependent manner by interacting with a MAPK protein (Huang, 2005).
1.3. C. elegans and hypoxia
C. elegans is a soil nematode and is found on rotting vegetation in the wild (Duveau &
Félix, 2012). Under favorable environmental conditions (abundant food, low population
density and moderate temperature) C. elegans develops from egg through four larval
stages to reach reproductive maturity within 3-5 days. After hatching, worms of the L1
stage comprise 558 cells and develop through 3 more larval stages, L2—L4, each
marked by ecdysis and stage-specific patterns of cellular events. The cellular events
including neuronal, epidermal, and gonadal cell lineage cell divisions and
morphogenetic events like gonadal and vulval formation lead to the final 959 somatic
cells in hermaphrodite animals. The small body size, ease of culture, short generation
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time, and relatively easy forward and reverse genetics makes C.elegans a very
desirable genetic system (Powell-Coffman, 2010).
Environmental oxygen might be limited or fluctuating in natural habitats enriched for
microbial food especially deep in the soil (Voorhies & Ward, 2000). C. elegans do not
have complex respiratory and circulatory systems and the cylindrical body and simple
gut design favors diffusion of oxygen across the gut lumen and cuticle. C. elegans are
able to sense various oxygen tensions and prefer a 5-12% O2 concentration (Gray et
al., 2004). Although it is sensitive to low concentrations of oxygen, the worm has
evolved several mechanisms to survive the stress of hypoxia/ anoxia. Adult worms are
able to maintain a steady metabolic rate even when exposed to a range of decreasing
oxygen tensions. Metabolic rates begin to drop for young adults at oxygen tension lower
than 3.6 kPa (~2%) (Anderson, 1976; Voorhies & Ward, 2000). At concentrations below
0.2% hypoxia, metabolic rate drops to as low as 5% of that in normoxic conditions
(Voorhies & Ward, 2000). At every stage of development C. elegans survive 24 hours of
severe hypoxia at a rate of 90% or greater (Padilla, Nystul, Zager, Johnson, & Roth,
2002; Voorhies & Ward, 2000).
So, how is the worm so adept at dealing with hypoxia? When confronted with oxygen
deprivation the worm responds by remaining animated or entering into suspended
animation depending on oxygen concentration and metabolic state (Nystul & Roth,
2004). Worms remain active in hypoxia, while they enter a state called suspended
animation in anoxia and severe hypoxia (≤0.1%). This ‘suspended animation’ response
is mediated by the spindle checkpoint protein SAN-1 in a HIF-independent manner in
embryos and the ceramide synthase HYL-2 in adults although the factors critical in this
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decision are unclear (Budde & Roth, 2011). After non-lethal exposures to anoxia the
animals will resume biological processes such as cell division, development, eating,
movement, and offspring production (Miller & Roth, 2009). Survival in severe hypoxia/
anoxia depends upon developmental stage, growth temperature, diet, and genotype. C.
elegans are more sensitive to hypoxia if the temperature during exposure is increased
(>24°C) or if the duration of anoxia exposure is increased (Mendenhall, LaRue, &
Padilla, 2006). The most severe hypoxia/ anoxia tolerant developmental stages are
dauer larvae and embryos (Padilla et al., 2002).
Extended survival in severe hypoxia and anoxia necessitates metabolic changes and
cell cycle in the embryo. When exposed to severe hypoxia, the embryo arrests cell cycle
progression at either the interphase, last prophase, or metaphase stages and modifies
its metabolic pathway to adapt to the reduction in the ratio of ATP/AMP (Padilla et al.,
2002). Indeed carbohydrate homeostasis is critical for survival in severe hypoxia/
anoxia; for instance, a 24-hour anoxia treatment resulted in a decrease in glycogen
levels to approximately 20% of the initial levels (Iii & Roth, 2010), suggesting that
glycogen perhaps plays an important role in maintaining metabolism during anoxia
exposure. Additionally, knockdown of gsy-1, the glycogen synthase, renders the
embryos sensitive to the severe hypoxic. Moreover, the environment to which the parent
is exposed can influence the survival rate of its embryos; the embryos of adults treated
to a high salt environment (300 mM sodium chloride) are sensitive to anoxia insult (Iii &
Roth, 2010). The uterus of an adult provides unique protective abilities in severe
hypoxia. Embryos within the uterus of gravid adults exposed to 0.1% of hypoxia the
embryos survive by arresting and going to suspended animation (Miller and Roth,
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2009). In contrast, embryos that are laid on agar plates and then treated to severe
hypoxia for 48 hours do not survive (Budde & Roth, 2011).
1.3.1 C.elegans HIF-1
In terms of HIF function and regulation, C.elegans has several advantages. The genes
and pathways that govern hypoxia, including the oxygen-dependent stability of HIF-1
are conserved, and there is no redundancy in the corresponding counterparts. For
instance, C. elegans has a single HIFα homolog, termed HIF-1; and a single HIFβ
homolog, termed AHA-1 (Jiang et al., 2001). Compared to three paralogues PHDs in
mammals, there is one homolog, EGL-9, in C. elegans, while VHL-1 is the single VHL
homolog in C. elegans (Epstein et al., 2001). The reduced complexity of the HIFpathway facilitates interesting genetic analysis (Epstein et al., 2001; Powell-Coffman,
2010). Further, while the hif-1α -/- mouse dies by E10.5 with severe vascular defects,
hif-1(ia4) mutants are viable in normoxia (Powell-Coffman, 2010; Ryan et al., 1998).
C.elegans hif-1 gene has 42% identity and 67% similarity to human HIF-1α in the bHLH
domain, and it has 30% identity and 55% similarity to HIF-1α in the two PAS core
domains C. elegans hif-1(ia04) loss-of-function mutant is a 1,231-bp deletion of the
second, third, and fourth exons, resulting in the deletion of most of the bHLH and PAS
domains, a shift in frame, and a premature translational stop.
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Figure 1.3: Genomic structure of C.elegans hif-1 and hif-1(ia4) mutant: C.elegans hif-1
has conserved PAS and bHLH domains. The ia04 mutation is a 1,231-bp deletion of the
second, third, and fourth exons. This introduces a frameshift and premature stop in the
mutant mRNA.

hif-1(ia04) mutants are viable under normal conditions, although they fail to adapt to
hypoxia (0.5% or 1% oxygen a 20°C) (Jiang et al., 2001; Padilla et al., 2002). A
microarray study of the L3 larval stage treated to 0.1% hypoxia identified 62 mRNAs,
including transcription factors, metabolic enzymes, and signaling molecules, that were
differentially regulated by HIF-1 (C. Shen et al., 2005). HIF-1 also modifies neuron
function and development in low oxygen conditions. A short exposure to hypoxia
modifies the aerotaxis of worms from the preferred 10% oxygen to 8% oxygen in a HIF1-dependent manner (Chang, Chronis, Karow, Marletta, & Bargmann, 2006). Moreover,
HIF-1 induces the expression of TYR-2 tyrosinase in the ASJ neurons to antagonize
germline apoptosis triggered by CEP-1, the homolog of p53 (Sendoel, Kohler, Fellmann,
Lowe, & Hengartner, 2010). In a manner similar to aberrant brain development in
hypoxia in mammals, hypoxia induced HIF-1 stabilization led to defective axon guidance
and neuronal migration in C. elegans (Pocock & Hobert, 2008).
1.3.2. Regulation of C.elegans HIF-1
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The PHD/VHL-1 pathway regulating HIF-1 protein stability is conserved from mammals
to C.elegans (Epstein et al., 2001; Jiang et al., 2001). Besides the regulation of the HIF1 protein, the expression of hif-1 s also tightly regulated. In normoxia, the HIF-1 subunit
is regulated by EGL-9, VHL-1, protein scaffolding protein SWAN-1, and the
transmembrane acyl transferase RHY-1 (Shao, Zhang, Ye, Saldanha, & PowellCoffman, 2010; C. Shen, Shao, & Powell-Coffman, 2006). The expression of HIF-1
target genes was markedly higher in egl-9(sa307), vhl-1 (ok161), swan-1 (ok267), and
rhy-1(ok1402) mutants (Shao et al., 2010; C. Shen et al., 2005, 2006).
1.3.3. Non-traditional roles of C.elegans HIF-1
In addition to mediating hypoxia adaptation, C.elegans HIF-1 is important for combating
several stresses. HIF-1 mediated heat acclimation at 25°C protected worms from
severe heat stress (35°C), sodium azide treatment, and heavy metal stress (cadmium)
(Treinin et al., 2003). Interestingly, mammalian HIF-1 also contributes to heat
acclimation-induced neuroprotection (Shein, Horowitz, Alexandrovich, Tsenter, &
Shohami, 2005). C. elegans HIF-1 is involved in pathogen responses (Shao et al.,
2010), dauer formation (C. Shen et al., 2005), protection against bacterial pore-forming
toxins (Bellier, Chen, Kao, Cinar, & Aroian, 2009),.and resistance to high concentrations
of hydrogen sulfide and hydrogen cyanide (Budde & Roth, 2010, 2011). Several studies
have also explored the HIF-1’s role in modulating C. elegans lifespan, although the
results vary from one lab to the other. Moderate over-expression of HIF-1 increases
lifespan, but the effects of loss of function mutation of hif-1 is variable depending on
temperature, food conditions, and small differences in hypoxia concentration (D. Chen,
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Thomas, & Kapahi, 2009; Mehta et al., 2009; Muller, Lustgarten, Jang, Richardson, &
Van Remmen, 2007).
1.4. Beyond HIF-1: Exploring HIF-independent pathways in hypoxia
It is evident that the HIF-1 is a crucial gene regulating diverse responses for hypoxia
adaptation. However, there are several gaps in our knowledge of how cells combat low
oxygen challenges.
Though the HIF-1 pathway is thought to be the primary regulator of hypoxic responses,
its actions in any system do not account the entire hypoxic response. Data from
mammalian cells show that HIF-1α is dispensable for hypoxic upregulation of a host of
transcripts (Wood et al. 1998). Studies on CHO cells defective for HIF-1 function
showed that well recognized oxygen-regulated proteins including GRP78 and heme
oxygenase 1 (HO-1) were regulated independent of HIF-1 (Dachs & Stratford, 1996;
Roll et al., 1991) Despite the ubiquitous presence of the HIF pathway, the hypoxia
responses vary significantly from cell-type to cell-type, suggesting that HIF-1 and other
factors collectively refine hypoxic responses in accordance with cell-specific needs
(Ryan, Lo, and Johnson 1998; Carmeliet et al. 2014). For instance, VEGF expression in
colon cancer in hypoxia is dependent on the k-ras and not hif-1. In contrast, the
regulation of VEGF in pancreatic and hepatocellular cancer cells is entirely hif-1
dependent (Mizukami et al., 2004). Considering some hypoxia-response genes are
induced in the presence and absence of HIF-1 as in the case of HO-1, it is likely that the
same gene is regulated by HIF-1 and other HIF-independent factors depending on the
cell type and oxygen concentration (Roll et al., 1991; Wood et al., 1998). It is interesting
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to nore that regulators of immune function—c-Myc, NF-KB, and AP-1—also regulate
hypoxia- responsive genes in a HIF-1-independent manner in hypoxia (Mizukami,
Kohgo, & Chung, 2007).
Largely explored in the context of cancer, two pathways are involved in a HIFindependent hypoxia response to influence gene expression and cell behavior in
mammals. The first is mammalian target of rapamycin (mTOR) pathway that mediates
the hypoxia response via several pathways. In response to growth and metabolic
signals, mTOR, as part of mTOR complex 1 (mTORC 1), controls the translational
machinery by phosphorylating ribosomal protein S6 kinase (p70S6K), eukaryotic
elongation factor 2 kinase (eEF2 kinase) and eukaryotic translation initiation factor 4E
(eIF4E) binding protein 1 (4E-BP1) (Hay & Sonenberg, 2004). The mechanism by which
hypoxia regulates mTOR is not clearly defined, although it is suggested that the
activation of the tuberous sclerosis protein I (TSC1)-TSC2 complex and hypoxiaresponse gene REDD1 contribute to the inhibition (Brugarolas et al., 2004). The final
outputs are reduced protein synthesis and induction of apoptosis; however, the
molecules mediating the this response are yet to be uncovered (Wouters & Koritzinsky,
2008).
The lack of oxygen and hence, the lack of a terminal electron acceptor, impairs
disulphide bond formation and impairs protein folding in the ER. This subsequently
activates the unfolded protein response (UPR), although little is known about the
molecules that sense changes in oxygen and mediate the response (Ron & Walter,
2007). By an unknown mechanism, hypoxia activates ER stress sensors, including
PKR-like ER kinase (PERK) and inositol-requiring protein1 (IRE1) (Koumenis et al.,
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2002). Several studies have established a role of XBP-1, the downstream target of IRE1, with the pathogenesis of neoplasias. For instance, XBP-1 mediates the UPR in solid
hypoxic tumors and is essential for hypoxia survival (Romero-ramirez et al., 2004).
Consequently, owing to hypoxia derived ER stress, translation is inhibited thereby
preventing the accumulation of unfolded proteins in ER, and ER-associated degradation
(ERAD) and autophagy are induced to remove misfolded proteins (Bernales, McDonald,
& Walter, 2006; Koumenis et al., 2002; Romero-ramirez et al., 2004)
Compared to studies in mammals, more progress has been made in isolating HIFindependent mediators in hypoxia in model organisms. Shen et al. (2005) found 110
hypoxia response genes in C. elegans, 47 of which were induced in the absence of HIF1 (C. Shen et al., 2005). These HIF-1-independent genes included genes involved in
energy metabolism, signaling, extracellular matrix modeling, and heat shock proteins.
Moreover, Lee et al (2013) reported that the HIF-independent gene hsp-16.1 is
regulated by hypoxia-specific chromatin remodeling involving chromatin modifiers isw-1
and hda-1, histone H4, and NURF-1 (J. Lee & Lee, 2013).
We had previously conducted studies in Drosophila to identify HIF-dependent and HIFindependent transcripts in hypoxia. Our studies showed that like HIF-1, the orphan
nuclear hormone receptor Estrogen-Related receptor (dERR) regulates a large set of
regulated by HIF-1, but a sizeable number of transcripts regulated by ERR were HIF-1independent. This result was in concert with the role of mammalian ERR in hypoxia;
ERR was found to participate in hypoxic responses with HIFs (Ao, Wang,
Kamarajugadda, & Lu, 2008), as well as separately from HIF-1 upregulating VEGF and
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angiogenesis (Narkar et al., 2011). Moreover, the hypoxic regulators of a large set of
ontologically diverse transcripts, are unaccounted for.
In conclusion, there remain substantial gaps in our knowledge regarding the regulators
of hypoxic-induced transcription. The regulation of a large cohort of hypoxia response
genes in C.elegans, Drosophila, and mammalian cells cannot be explained by the
actions of HIF alone and existing data strongly suggest a HIF-independent player that
works parallel with HIF-1 in hypoxia. What is the mediator of the HIF-independent
response? Is this mediator regulated in the same manner as HIF1? Does this mediator
function in concert with HIF-1 or does it regulate a separate pathway for hypoxia
adaptation? This thesis describes my efforts to resolve some of these unresolved
questions.
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Aims

Graphical representation of hypothesis

I hypothesized that an unidentified factor (xx) acts in parallel to but separate from the
HIF-1 pathway to regulate transcriptional responses for hypoxia adaptation (Figure 2.1).
We proposed to use the C.elegans to test this hypothesis because of the following
reasons: (1) superior tools available for genetic manipulations; (2) conservation of
hypoxia responses in worms and mammals; (3) viability of hif-1(ia4) mutants in
normoxia. Since the well-established regulators of hypoxic transcription fulfil the same
functions in mammals and C.elegans, we anticipated that the newly identified players in
C.elegans is likely conserved in mammals. Given the pervasive influence of HIF in
disease progression, we expected the HIF-independent transcription factors to also play
similarly influential roles.
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Aim 1. Establish hypoxic sensor animals that report on HIF-dependent and HIFindependent actions. I planned to use hypoxia-sensitive genes that are expressed in a
HIF-independent manner to generate animals that report on pathway-specific hypoxic
activation. Generation of these transgenic animals will enable us to view how specific
treatments or genetic backgrounds influence hypoxia responses and allow for the
targeted disruption of one hypoxic response pathway over another.
Aim 2. Identify essential regulators of non-HIF-mediated hypoxia responses by
RNAi screen. Using hypoxia, I planned to conduct an RNAI screen for factors that
specifically target non-HIF-mediated responses, while leaving the HIF pathway
functionally intact. I then sought to explore downstream targets of the HIF-independent
transcription factor and determine how hypoxia adaptation is compromised in loss of
function mutations of the HIF-independent factor
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3. Materials and Methods
3.1: Custom hypoxia chamber for C.elegans
Our lab had previously used hypoxia chambers for inducing hypoxia in flies and cells.
To understand if the hypoxia chambers available in lab could be used to induce hypoxia
in worms, I used a visual assay using a previously generated reporter of HIF-1 function.
The expression of nuclear hormone receptor nhr-57 is induced by hypoxia and a
reporter construct in which the expression of GFP is controlled by the promoter of
nhr57:GFP has been previously established. Upon hypoxia treatment, nhr-57:GFP
levels increase markedly. The reporters were treated to 0.5% hypoxia in the Hypoxia
Incubator Chamber, which was previously used to treat flies. The Hypoxia Incubator
Chamber is a sealed chamber with a surface-type seal and an inlet for pre-mixed gas. I
used 0.5% oxygen CO2 premade gas for this purpose. Once the gas is purged in, the
O-ring is uniformly compressed by a ring clamp for an air-tight seal. Surprisingly,
following hypoxia treatment, the nhr57:GFP reporters failed to show GFP induction.
Moreover, qPCR experiments showed that there was no induction of nhr57 mRNA
expression upon hypoxia treatment. This suggested that the worms were not
experiencing hypoxia in the hypoxia incubator chamber, possibly because the gas was
escaping through the O-ring in spite of tight sealing.
C.elegans elicits different physiological responses in different conditions, which
highlights the importance of having tight experimental control over the hypoxic
concentration of O2. Hence, I decided to collaborate with Coy Laboratory to design a
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custom hypoxia chamber. Coy Labs has developed a wide array for hypoxia and anoxia
chamber for cell culture. We decide to modify the chamber in the following manner:
The Coy Lab hypoxia chamber for cells has a small glove box that is connected to a
bigger hypoxia compartment with a door. All the manipulations are conducted in the
glove box to minimize gain of oxygen from the bigger compartment. The hypoxia
chamber contains the regulators and flow meters and the fixed oxygen sensor
consisting of a galvonic electrode with a gold cathode to monitor the oxygen level. For
inducing hypoxia in worms, we decided to adapt the hypoxia chamber to only include
the glove box. Hence, the regulators, flow meters, and sensor is now on the glove box.
Owing to its smaller volume and omission of the temperature and carbon dioxide inlets,
the system became cheaper and more effective at maintaining low oxygen
concentrations. Gases are introduced through a unique gas tube shower system that,
along with the internal fan, provides the circulation required for uniform gas distribution
and fast response of the controller.

Figure 3.1: Modified Coy Lab hypoxia chamber for
C.elegans
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Instead of pumping pre-made oxygen gas and then starting the system, we decided to
apply a continual flow method using a nitrogen cylinder. We found that apart being far
cheaper (200$ per oxygen tank to 12$ per nitrogen tank), a continual system ensures
rapid equilibration of the chamber and increases the stability of the system.
Setting up hypoxia chamber: One-eighth-inch outer-diameter tubing was used with snap
connectors for all connections. The tubing has to be unreactive with O2 and we used
such as fluorinated ethylene propylene. The compressed gas tank is connected to a
rotameter (Aalborg) that acts as a flow control device. The upstream pressure from the
tank must be within the range of the flow device and the hose barb fittings.
Treating worms to hypoxia: Worms are transferred onto the plates and placed in the
chamber. The oxygen concentration is then adjusted. For short-term studies (24 hours),
plate dessication is not necessary, but for long-term studies, a plate with distilled water
must be placed in the chamber. Once the treatment is over, plates should be removed
and worms immediately collected within a minute for further applications. For qPCR
experiments, collect worms with cold M9.
Verifying Pnhr57::GFP expression in hypoxia: To ensure that the chamber induces
hypoxia appropriately, I used the HIF-dependent reporter Pnhr57::GFP as a visual
assay. I saw consistent Pnhr57::GFP expression from 0.1%--0.5% hypoxia, thus
verifying the utility of the hypoxia chamber. A representative experiment is shown in
Figure 3.2.
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NORMOXIA

HYPOXIA

Figure 3.2: The HIF-dependent reporter Pnhr-57:GFP is induced following
0.1% hypoxia treatment Reporters were treated for 5 hours for a range of hypoxia
concentrations from 0.1—0.6% and the reporters showing GFP fluorescence were
scored. The HIF-1 dependent reporter was induced reliably until 0.5% hypoxia (as
shown in the figure). The images on the left image are DIC, while those right are
taken using fluorescence microscope Scale bar: 10uM
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3.2: Strains
Worms were maintained as described (Sulston and Hodgin 1988) with the following
modifications: grown on NGMSR plates (Avery 1993) at 20° on E. coli strain
HB101 unless indicated differently.
The wild type strain was C. elegans variant Bristol, N2. The blmp-1 (tm548) mutant was
generated by the National Bioresource Project in Japan; it contains an 810 bp deletion
that has been described elsewhere (Huang et al. 2014b). We acquired it from Dr.
Horvitz then out-crossed it 10 times against N2 (the outcrossed strain is calledYJ55).
The hif-1 mutant strain is ZG31 hif-1(ia4), carrying a 1,231 bp deletion (JIANG et al.
2001).
The egl-9 allele (sa307) contains a 243 bp deletion (Darby et al. 1999).
The 3kb-F45D3.4::GFP reporter plasmid was generated by cloning the promoter
of F45D3.4 into pPD95.69 using the following primers: 5′- ataagctcacttgttaggtccaattggc3′ (forward containing a HindIII site) and 5′- atgagctcgtttatttcgagcggttgtg-3′ (reverse
containing a SacI site). The plasmid was injected into either the wild type or hif-1(ia4)
background to generate the respective reporter strains (YJ28 [uyEx3[myo-2::mCherry
pF45d3.4::GFP]

and

YJ36

[hif-1(ia4);uyEx3[myo-2::mCherry

pF45d3.4::GFP]]).

mCherry, under the control of a myo-2 promoter, was used as a transgenic marker. The
egl-9 reporter strain (YJ204) was generated by crossing YJ36 with CB6088 egl9(sa307) hif-1(ia4). For hypoxia treatment, animals were cultured on NGMSR plates in a
Coy hypoxia chamber with oxygen analyzer (Coy Laboratory Products, Grass Lake, MI).
Oxygen was kept constant using a continuous nitrogen gas source. For cobalt chloride
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treatment, a 100 mM stock solution was prepared and filter sterilized using a 0.22-μm
filter. 500 μl of the stock solution was added onto a 10 ml plate to make a final
concentration of 4.76 mM. The effect of cobalt chloride on worms was examined either
by a western blot assay to measure HIF-1 protein, by qRT-PCR to assess transcript
level, or by fluorescence microscopy to detect reporter gene expression induced by
hypoxia. cobalt chloride-induced GFP fluorescence lasts for at least 48 hours in our
reporter strain.
3.3. Hypoxia sensitivity assay
Assays for embryo viability at 0.5% or 2.0% O2 were performed as described previously
(PADILLA et al. 2012). In short, 15-20 1-day-old adults were allowed to lay eggs on a
NGM plate seeded with OP50 for 1 hour and then removed. The eggs were counted
and incubated in hypoxia (0.5% or 2.0% O2, 20°) for 96 hours using a hypoxia
glovebox workstation (Ruskinn Inc). Immediately after treatment, animals were
examined to determine the number of animals that survived the hypoxia treatment and
the developmental stage of survivors. At least three independent experiments were
performed for each condition.
3.4. RNAi screen
A bacteria-mediated feeding RNAi screen was performed as described (Fraser
et al. 2000) with the following modifications: The YJ36 strain was screened with the
clones of transcription factor genes from the Ahringer feeding library (Kamath and
Ahringer 2003). The plates contained NGM agar with 1 mM IPTG and 100 μg/ml
carbenicillin that were inoculated with bacterial cultures grown 16-18 hours for each
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targeted gene. L1 stage worms were then transferred onto clonal plates and left at 20º.
Adults were then subjected to hypoxia or cobalt chloride treatment.
3.5. Quantitative RT-PCR
For total RNA preparation, 1-day-old adults were grown on NGMSR plates at
20°, washed with M9 buffer and re-suspended in Trizol (Bioline). RNA extraction was
carried out by freeze-thawing 4 times in liquid nitrogen and then 250L chloroform was
added. Samples were vortexed for 30 seconds and spun down at 13,200 rpm for 10
minutes at 4°C. The aqueous phase was taken and 500L of isopropanol was added.
Samples were vortexed and then incubated at -20oC for 30 minutes. RNA was pelleted
at 13,200 rpm for 15 minutes at 4°C. The supernatant was removed and the RNA pellet
was washed with 75% ethanol. The samples were then centrifuged at 13,200 rpm for 10
minutes at 4°C. Supernatant was removed and RNA pellet was dried at 37°C. RNA was
then re-suspended in the appropriate amount of DEPC H2O depending on pellet size
and then incubated at 55°C for 10 minutes. Isolated RNAs were treated with DNase
(Promega, Madison, WI) in a 1:10 ratio with DNase and Buffer and incubated at 37°C
for 30 minutes. Following ethanol precipitation and air-drying, the pellet was dissolved in
DEPC water. cDNA was synthesized from 2 μg of RNA (Applied Biosystems, catalog
number# 438706). 2g RNA, 1L Random Hexamer Primer Mix, 1L 10mM dNTPs mix
were preheated at 95°C for 1 minute then cooled to 4°C. Then the 5x RT Buffer, 200U
Reverse Transcriptase, 10U RNase Inhibitors, and DEPC H2O was added to a final
volume of 20 L. The PCR was set as follows: 42°C for 50 minutes, 70°C for 15 minutes
and then cooled to 4°C.
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Real-time qPCR was performed using SensiMix SYBR and Fluorescein Kit (Bioline,
Taunton, MA) according to manufacturer’s instruction. Briefly, the cDNA was diluted to
1:20 ratio and then 5L of the cDNA was used as the template for the reaction. The
reaction mixtures for the genes were prepared as follows: 12.5 L of SYBR Green mix,
1 L 5 M forward primer, 1 L 5 M reverse primer, and 5.5 L of dH2O. All the
samples were assayed in three biological replicates and analyzed using a CFX96 RealTime PCR Detection System (Bio-Rad, Hercules, CA). ama-1 (RNA polymerase II) was
used for normalization.
3.6. Western blotting
Equal amounts of protein were mixed 1:1 with 2X Laemmli sample buffer containing 1
mM β-mercaptoethanol. Samples were incubated at 95°C for 5 mins and separated
using SDS-PAGE electrophoresis (running buffer: 25 mM Tris, 192 mM glycine,
0.1%SDS). The proteins were transferred to a nitrocellulose membrane and soaked in
transfer buffer (70% methanol, Tris-Hcl) (Millipore, Billerica, MA) using a wet transfer
apparatus (Bio-Rad, Hercules, CA). After trans-blotting, membranes were incubated in
blocking buffer (5% nonfat dry milk and 1% BSA in 0.5% TBST) overnight. Membranes
were incubated with antibody in 0.5% TBST (1% milk, 0.1% BSA). Antibodies used
were: anti-Ce-HIF-1 antibody (a gift from Dr. Peter Ratcliffe, Oxford; 1: 5,000 dilution);
AA4.3 anti-tubulin antibody (developed by Charles Walsh and obtained from the
Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and
maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242,
1:1000 dilution); anti-rabbit antibody IgG conjugated with HRP (Santa Cruz SC2030, 1:
5000 dilution); and anti-mouse antibody conjugated with HRP. The bands were detected
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using an ECL plus kit (GE Healthcare, catalog# RPN2133).
3.7. Microscopy
GFP-expressing worms were observed using a Zeiss Axio A2 Imager. Images were
acquired using Zeiss Axiovision software.
3.8. Chromatin Immunoprecipation (ChIP) assay
The ChIP assays were performed as described, with minor modifications (Niu et al.,
2011). L1 stage worms were grown at 20° and then treated with hypoxia at L3 or 1-day
adult stages. After treatment, worms were collected and washed and treated with M9
containing 750 μl formaldehyde for crosslinking. The samples were incubated at RT on
a shaker for 30 minutes. To stop crosslinking, 1M Tris-HCl was added and samples
were incubated on a shaker at room temperature for another 10 mins. The samples
were then spun down at 4°C, 450xg for 10 minutes. The supernatant was removed and
the pellet lysed in FA buffer (50 mM HEPES-KOH, pH7.5, 150 mM NaCl, 1 mM EDTA,
0.1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS and protease inhibitor 10
cocktail (Roche, 11836170001) by sonication (5 times at 10 s intervals). The samples
were then spun 4°C, 7000 rpm for 10 minutes. Supernatant (chromatin) was pre-cleared
as follows: 100 μl supertanant + 1 ml IP buffer (0.01%SDS, 1.1% Triton X, 1.2mM
EDTA, 16.7mM Tris-HCl, pH 8.0, 16.7mM NaCl) with inhibitors + 10μl ChIP beads (3X
washed protein G sepharose beads resuspended in equal volume of ChIP buffer with
10 μl of 1 mg/ml BSA per 100 μl beads and 5 μl of 10 mg/ml red herring DNA per 100 μl
beads) on rotator at 4°C for 30 minutes. Beads were pelleted to give a pre-cleared
chromatin. 200 μl was saved as input. The lysates were incubated overnight at 4° with
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either anti-GFP (Abcam ab290) or IgG (Millipore). The next day, 50μl ChIP beads were
added and samples were incubated on a rotator at 4°C for 2hrs. Beads were spun down
at 6000 rpm at 4°C for 1 min and were washed 2X (10 mins rocking at 4°C followed by a
spin at 6000 rpm for 1 min) with each of the following buffers: ChIP buffer I (0.1% SDS,
1% Triton X, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 150mM NaCl), ChIP buffer II (0.1%
SDS, 1% Triton X, 2mM EDTA, 20 mM Tris-HCl, pH 8.0, 500 mM NaCl), ChIP buffer III
(0.25 M LiCl, 1% NP.-40, 1% Sodium Deoxycholate, 1 mM EDTA, 20 mM Tris-HCl, pH
8.0) and ChIP buffer IV (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). DNA was then eluted
from the beads by adding 200 μL ChIP elution buffer (1% SDS, 0.1 M NaHCO3) and
rocking for 15 mins at room temperature. The beads were pelleted at 6000 rpm. Cross
linking was reversed by adding 8 μl 5M NaCl followed by incubating the supernatant
(and also the input sample that was saved previously) overnight at 65°C. 1 ml PB buffer
was added and samples were purified on miniprep columns. Final DNA was eluted with
50 μl buffer watee. DNA was recovered by phenol-chloroform extraction, precipitation,
and then eluted.
3.9. Tunicamycin treatment
Synchronized eggs of wild-type and blmp-1 mutants were plated onto standard plates,
counted, and allowed to hatch. After 24 hours, the L1s were treated with tunicamycin (1
ug/ml or 5 ug/ ml) for 24 hours and the adults were counted after 3 days. Three
independent experiments were conducted.
3.10. Statistical analysis
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Results are presented as the mean ± SE. Statistical comparison was performed using
two-tailed Student’s t-tests. A p-value less than 0.05 was considered statistically
significant and annotated by *.
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3.11. Primers used:
qRT-PCR

Sequence

mod-5 Forward

5'-tgggattccgaagttccgtg-3'

mod-5 Reverse

5'-tgacggagtggtcaatggtg-3'

zip-1 Forward

5'-ccgcctcatccaataaccga-3'

zip-1 Reverse

5'-tcctcctcggctggtatgaa-3'

F44E5.5 Forward

5'-ggaggaggtacatttgatgtttc-3'

F44E5.5 Reverse

5'-tcgttgatcaaagtcttctcct-3'

icl-1 Forward

5'-agcagaccagattgaagcctgtga-3'

icl-1 Reverse

5'-cagccaaacgagacgcattcaagt-3'

ama-1 Forward

5'-aacgcggtaccatcagtttc-3'

ama-1 Reverse

5'-ggacgacgtgttcctacgat-3'

fmo-12 Forward

5’-aacggtacagtcagaatcaagccaa-3’

fmo-12 Reverse

5’- actaactggaaccaactttccgtgt-3’

egl-9 Forward

5’-atccggaaatctactgactcgggagta-3’

egl-9 Reverse

5’-tgggagcccttcgtctagatctt-3’

nhr-57 Forward

5’-gtatgccggaaaaagaacga-3’

nhr-57 Reverse

5’-atgcaggggaagatgaacag-3’

ChIP primers
cF45 F

5'-agacagtgatagaggaatgtaaacac-3'

cF45 R

5'-atattgccgccctgtagtcgt-3'

Cloning
F45D3.4 3kb Forward

5′-ataagctcacttgttaggtccaattggc -3′

F45D3.4 3kb Reverse

5′- atgagctcgtttatttcgagcggttgtg-3′
5’- gatc aagctt cga aaa cga caa cac cga atg
cg–3
5’ - aatt ccg cgg gtt tat ttc gag cgg ttg tg – 3’

F45D3.4 5kb Forward
F45D3.4 5kb Reverse
Genotyping
HIF Geno Forward

5’- gat tga agg tgg agt agc gcc –3’

HIF Geno 1 kb Reverse

5’ -cgg agc cag atc cac atc gaa t-3’

HIF Geno in Reverse

5’- gttttctattgctcacctgt – 3’
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4. Results
4.1: C.elegans hif-1 mutant phenotype
Organismal effects of hypoxia have been explored by examining the viability to
adulthood of C. elegans embryos. Embryos laid by wild-type (N2) and hif-1 deletion
mutants survive in house air O2 concentrations (21% O2). N2 worms are able to adapt
and survive to adulthood in 0.5% O2, while hif-1 embryos cannot, thereby underscoring
the importance of HIF-1 for hypoxia adaptation (Iii & Roth, 2010). However, another lab
reported the hif-1 mutants can survive 0.5% O2 but cannot survive 0.3% O2 (C. Shen et
al., 2005). Owing to these discrepancies, I sought to find the concentration at which
HIF-1 is stabilized for hypoxia adaptation. I conducted a dose response study with wild
type and hif-1 mutants and scored for the lethality phenotype of hif-1 mutants.
Some labs conduct hypoxia lethality studies by placing embryos in continuous hypoxic
treatment of worms for 5 days (Padilla, Goy, & Hajeri, 2004). Our chamber is inefficient
at maintaining hypoxia concentrations for extended periods of time (oxygen sensor
needs to be recalibrated after 48 hours continuous treatment), and hence, I modified the
lethality assay to include shorter but harsher treatment to the embryos for 24 hours.
Accordingly, embryos from wild type and hif-1 mutants were treated to hypoxia for 24
hours, and then reared in normoxia for 3 days. Embryos that survived the insult and
became adults were counted. As seen in Figure 3.1, hif-1 mutant embryos cannot
survive harsh hypoxia treatment at 0.1% and the number of surviving hif-1 mutants
correlated with oxygen concentration. The lethality phenotype was not observed after
2% hypoxia and since the Ce-HIF-1 antibody is not commercially available, we were
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unable to look at HIF-1 stabilization at the different oxygen conditions. However, we
confirmed via western blotting that HIF-1 is stabilized following 12 hours treatment in
0.1% hypoxia. Thus, we established that the HIF-1 pathway is activated at oxygen
concentrations below 2% and there exists a dose dependent relationship between
survival of hif-1 mutants and oxygen concentration.
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Figure 4.1. Dose dependent response of hypoxia treatment: (A) Wild type and hif1(ia4) mutant embryos were counted and treated to the indicated concentration of
hypoxia for 24 hours, following which worms were allowed to proceed to adulthood in
normoxia. The percentage of worms surviving to adulthood after hypoxia treatment is
plotted. (B) Western blot depicting stabilization of HIF-1 protein following 01% hypoxia
treatment
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4.2. HIF-dependent and HIF-independent genes in hypoxia in C. elegans
Previous studies have demonstrated the necessity and importance of non-HIF pathway
mediated transcriptional responses in hypoxia (J. Lee & Lee, 2013; Li et al., 2013; C.
Shen et al., 2005). By microarray studies, Shen et al (2005) had identified transcripts
that were regulated in a HIF-1-dependent and HIF-1-independent manner in L3 larvae
treated to 0.1% hypoxia for 4 hours. In order to verify the results of the microarray, I
conducted qRT-PCR analysis of 2 candidate genes for each category (Figure 3.2.a).
Expressions of nhr-57, a nuclear hormone receptor of unknown function, and fmo-2, a
flavin monoxygenase, as HIF-1-dependent targets and F45D3.4 and F44E5.5, an hsp70 protein, as HIF-1-independent targets were evaluated.
We validated that nhr-57 and fmo-2 is normally induced in wild-type larvae when they
are subject to 0.1% O2 treatment for 12 hours. Further, we confirmed that the response
is HIF-dependent by demonstrating that the induction of the genes in hypoxia is
diminished in the hif-1 mutant background. We next validated that the HIF-1independent genes and found that F45D3.4 and F44E5.5 are normally induced in wildtype larvae following a 0.1% O2 treatment for 12 hours. The response is HIFindependent as the induction in hypoxia is maintained in hif-1 mutants. Moreover, basal
values of most of these genes were plotted to ensure that there was no added variability
owing to genotype. A representative plot for the basal expression of F45D3.4 is shown
in Figure 3.2.b.
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Figure 4.2.a. Hypoxia induces HIF-dependent and HIF-independent genes Wild
type and hif-1 mutant adults were treated to 0.1% hypoxia for 12 hours and qRT-PCR
was conducted for 2 HIF-dependent targets (top row) and 2 HIF-independent targets
(bottom row) **p<0.01. Data are expressed as mean ± SEM.

Figure 4.2.b. Expression of HIF-independent gene F45D3.4 was not altered in
basal conditions. The expression levels of F45D3.4 were determined in wild type and
hif-1 mutant adults at normoxia by qRT-PCR. Data was normalized to wild type
normoxia. Data are expressed as mean ± SEM
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4.3: 3kb-F45D3.4::GFP is a hypoxia-dependent HIF-independent reporter
To develop a visual assay for HIF-1-independent transcriptional activity, I generated
transgenic reporter lines in both the wild-type and hif-1 mutant backgrounds, where
GFP was placed under the control of elements controlling F45D3.4 expression. I
generated 5-kb and 3-kb promoter constructs and found that the 5kb-F45D3.4::GFP
construct was expressed at high levels even in normoxia. The 3-kb-F45D3.4::GFP
construct showed negligible expression in normoxia, and following a 12-hr hypoxic
treatment in a chamber containing 0.1% O2, I found that the proximal 3-kb region of the
F45D3.4 promoter was sufficient to drive reporter expression in wild-type and hif-1
mutant backgrounds (Figure 3.3).
These data confirm that F45D3.4 is a HIF-independent hypoxia response gene and
suggest that the regulatory elements mediating the response localize to a 3-kb region
that flanks the F45D3.4 transcription start site.

37

Figure 4.3. HIF-independent transcriptional regulation of F45D3.4 in hypoxia A)
Schematic of HIF-independent reporter 3kb-F45D3.4::GFP B) Expression of GFP in
wild type and hif-1(ia4) mutant backgrounds carrying the 3kb-F45D3.4::GFP construct
after treatment in normoxia and hypoxia for 12 hours. Scale bars indicate 10 μm.
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4.4. Cobalt chloride mimics hypoxia in C.elegans
Considering that one of the major goals of the study was to conduct a screen, we found
that the size of the hypoxia chamber was restrictive because only a limited number of
plates could fit in the chamber. Hence, we decided to explore other options for inducing
hypoxia in the worms. Cobalt chloride is widely used as a hypoxic mimetic in cells,
because it can elicit normoxic transcriptional responses that greatly resemble those
seen in hypoxia (Vengellur & LaPres, 2004); however, its utility in recapitulating
transcriptional hypoxic responses in C.elegans had not been demonstrated. Since it is
easier to treat several plates to cobalt chloride at once as opposed to the hypoxia
chamber, we decided to conduct the screen using cobalt chloride as a hypoxia mimetic,
and then verify the results with the hypoxia chamber.
The utility of cobalt chloride as a hypoxia mimetic was tested by three approaches: (1)
Does cobalt chloride stabilize HIF-1 protein? (2) Does cobalt chloride treatment induce
the expression of hypoxia-dependent genes? (3) Does cobalt chloride induce the HIFindependent reporters?
First, I grew worms on plates containing 4.76 mM cobalt chloride for 12 hours and
asked if the treatment affected HIF-1 protein levels. We found that cobalt chloride
caused a marked increase of HIF-1 protein in control animals that is similar to the
accumulation seen in hypoxia. The cobalt chloride treatment also induced a robust
transcriptional upregulation of the F45D3.4 transcript in wild-type animals and hif-1
mutants in a manner that resembled previous hypoxic treatments. Similarly, a separate
HIF-independent transcript, F44E5.5 (C. Shen et al., 2005), was also upregulated by the
treatment. These results suggest that cobalt chloride treatment triggers a transcriptional
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response that mimics hypoxic treatment, impacting both HIF- and non-HIF-mediated
pathways. Finally, I tested whether the 3-kb-F45D3.4::GFP reporter responded to cobalt
chloride and found the cobalt chloride robustly induced GFP expression in the reporters
(Figure 4.4)
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Figure 4.4.a. Cobalt chloride mimics hypoxia treatment in C.elegans
A) Expression of GFP in a wild type animal and a hif-1(ia4) mutant carrying the 3kbF45D3.4::GFP construct after treatment in 4.76 mM cobalt chloride. Scale bars indicate
10 μm B) Stabilization of HIF-1 protein was monitored by western analysis following
normoxic, hypoxic, and cobalt chloride (4.76 mM) treatments for 12 hours in wild type
and hif-1(ia4) mutants. Tubulin signal served as a loading control. (C&D) Total mRNA
was collected from wild type animals and hif-1(ia4) mutants after incubation on mock- or
cobalt chloride-treated (4.76 mM) plates for 12 hours to measure the expression of the
HIF-independent genes F45D3.4 (C) and F44E5.5 (D) by qRT-PCR. Normalized values
are the average of at least three biological replicates. Error bars are SEM. * indicates a
p-value < 0.05, while the p-value for ** is < 0.01. Student’s t-test was used to determine
significance.
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Consistent with the effects observed on the endogenous F45D3.4 transcript the 3-kbF45D3.4::GFP reporter animals also responded to cobalt chloride in a concentrationdependent manner in wild type and hif-1 mutant backgrounds. I found that 4.76 mM
induced maximum response in reporters of both background. Next, I looked at percent
lethality at this concentration in both reporters. Up to 16 hours of cobalt chloride
treatment did not diminish survival but treatments beyond that time tended to negatively
impact survival of the wild type and hif-1 backgrounds equally, suggesting the loss of
HIF action was not an important factor in the susceptibility to cobalt chloride treatment.
GFP induced by cobalt chloride treatment lasted for at least 48 hours after treatment
was stopped.
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Figure 4.4.b. Testing the cobalt chloride response in C.elegans
A) Transgenic F45D3.4 worms were treated on plates containing 4.76 mM cobalt
chloride to measure the effect on lethality of prolonged exposure to cobalt chloride B)
the hypoxic and cobalt chloride-elicited responses in the indicated backgrounds over
time C) 4.76 mM is the optimal concentration of cobalt chloride that elicits maximum
response in wild type or hif-1(ia4) mutants. All data points represent the average of at
least 2 different biological pools consisting of at least 20 individual animals.
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4.5: Effect of variety of stresses on the HIF-independent reporter
As is the case with cobalt chloride treatment, stimuli other than low oxygen can
transcriptionally upregulate hypoxic response genes. To better understand the upstream
mediators of the HIF-independent response and to determine how they may differ from
those controlling HIF-dependent responses, we subjected 3kb-F45D3.4::GFP reporter
animals to different cellular stresses and compared the responses to results obtained
from nhr-57::GFP reporter animals, a previously described HIF-dependent reporter line
that also responds to hypoxic treatment (C. Shen et al., 2006). Unexpectedly, the nhr57::GFP reporter was not activated by cobalt chloride treatment (1.42 - 4.76 mM) like
the 3kb-F45D3.4::GFP reporter. In spite of the difference in responsiveness to cobalt
chloride, the two reporters behaved quite similarly when subjected to atmospheric or
low levels of oxygen; neither was active in normoxia (~21% O 2). I wanted to ascertain
that the GFP induction was specific to hypoxia and was not a general stress response. I
subjected the reporters to various treatments, some of which are known to elicit HIFand/or non-HIF-pathway responses, and scored for lack of GFP induction. Oxidative
stress activates the HIF-1 pathway via reactive oxygen species (Eom, Ahn, Kim, & Choi,
2013). Treatment of nhr57:GFP reporters to the herbicide paraquat, which causes
mitochondria to generate superoxide anions, resulted in activation of the HIF-dependent
reporter. As opposed to the HIF-dependent nhr57:GFP control, the HIF-independent
reporter did not show GFP expression suggesting that the ROS as those generated by
paraquat does not induce this reporter even if HIF-1 is present. Further, Lee et al.
(2013) had recently reported that calcium ions are necessary for the induction of a HIF1-independent gene-hsp-16.1-in hypoxic conditions (J. Lee & Lee, 2013). To test if the
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disruption of the cellular calcium balance affected the hypoxia response of reporter, I
treated the 3kb-F45D3.4:GFP reporter with EGTA, which specifically chelates calcium
(J. Lee & Lee, 2013). I also looked at some other stresses including hypertonic stress
(300 mM NaCl) (Iii & Roth, 2010), heat-shock (37° for 6 hours) (Treinin et al., 2003),
and, heavy metal exposure (0.02 mM NiCl2) (Murphy et al., 2011). Interestingly, HIF-1independent reporters when stressed with starvation (I. Lee, Hendrix, Kim, Yoshimoto,
& You, 2012), showed GFP induction even without hypoxia treatment.
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Table 1: Effects of stresses on the expression of HIF-independent reporter The
reporters were treated as listed and GFP induction scored.
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4.6. A transcription factor RNAi screen for identifying candidate mediators of the
HIF-independent response.
We aimed to find transcription factors that facilitate non-HIF-mediated hypoxia-sensitive
responses. We conducted an RNAi screen using a commercially available library
comprising 387 transcription factors in the C. elegans genome. Since we were aiming to
isolate transcription factors other than hif-1, we conducted the screen using the hif1;3kb-F45D3.4::GFP reporter strain. Age matched reporters at L1 stage were fed
bacteria containing individual RNAi clones and grown to young adulthood in otherwise
normal conditions. At this point animals were treated with 4.76 mM cobalt chloride and
assayed 12 hours later for GFP expression. All clones were tested in duplicate on
individual batches of 40 animals per trial. Initial positive hits were considered those that
robustly inhibited GFP signal in at least 75% of animals (average ≥ 30 of 40 animals per
trial). The positive (14 transcription factors) hits were subjected to a secondary screen
where at least 100 animals were tested in duplicate.

Based on this screen, 8 transcription factors or 2.1% of the RNAi clones screened
showed loss of GFP expression following cobalt chloride treatment (Table 2). Each of
these positive RNAi genes was screened for GFP fluorescence following a 12-hour
treatment in 0.1% O2. Only three of the eight RNAi clones—tbx-38, lin-40, and blmp-1—
were capable of extinguishing hypoxia-induced GFP expression (Table 2).
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Figure 4.6.a. Schematic for RNAi screen
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Table 2. Results from screen Identified RNAi clones that inhibit GFP expression of the
HIF-independent pathway driven by cobalt chloride treatment or hypoxic exposure.
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The differential effectiveness of RNAi on suppressing GFP signal following the two
treatments, suggests that cobalt chloride and oxygen deprivation target distinct, but
overlapping upstream regulators of non-HIF-mediated pathways. We were interested to
see the effect of combination of cobalt chloride and hypoxia would result in an additive
effect. We tested for expression of F45D3.4 and zip-1 in a wild type background in the
presence of hypoxia, cobalt chloride, or both together. For F45D3.4, both treatments
together result in a response that is similar to either treatment alone. For zip-1, both
together have no apparent effect, whereas either treatment alone did. Hence, the
responses seen with the combination treatment seem to vary depending on the gene.
More studies exploring how each treatment may or may not interact with
other treatments at specific loci to alter the response are needed.
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Figure 4.6.b. Treatment with Cobalt chloride and hypoxia yields variable results in
C.elegans Total mRNA was collected from wild type animals and expression of
F45D3.4 (A) or zip-1 (B) in normoxia, hypoxia (0.1% O2), cobalt chloride (4.76 mM), or
both for 12 hours was measured by qRT-PCR. Error bars are SEM. ** indicates p value
<0.01. A student’s t-test was used to determine significance.
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4.7. blmp-1 mediates expression of a distinct subset of HIF-1-independent
hypoxia response genes
Of the three clones that were effective at mitigating GFP signal in both cobalt chloride
and hypoxia, we specifically focused on the zinc finger gene blmp-1, which we
confirmed was necessary for hypoxic-induced expression of the HIF-independent
transcript F45D3.4. The blmp-1 gene encodes a protein with 27% identity to mouse B
lymphocyte-induced maturation protein 1 (Blimp-1) and 26% identity to human positive
regulatory domain I-binding factor (PRDI-BF1). Both Blimp-1 and PRDI-BF1 are thought
to act predominantly as transcription repressors and are essential for the terminal
differentiation of B and T cells (Turner, Mack, & Davis, 2010), (Nutt, Fairfax, & Kallies,
2007).

Figure 4.7.a. Graphical representation of mammalian BLIMP-1 gene. BLMP-1 binds to DNA
using its zinc finger domain. Unlike other SET domain containing proteins, the PR domain in
BLMP-1 does not have methyltransferase activity

BLMP-1 is predicted to contain a positive regulatory (PR) domain, a nuclear localization
signal (NLS), and five Kruppel-type [(Cys)2-(His)2] zinc fingers (Figure 3.7.a). The zinc
fingers of both Blimp-1 and PRDI-BF1 have been shown to bind to target DNA and are
essential for their transcriptional repression activities (Lin, Wong, & Calame, 1997)
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(Ghosh, Gyory, Wright, Wood, & Wright, 2001). C. elegans BLMP-1 and mammalian
BLIMP-1 show striking domain conservation, with 43% similarity in the SET domain and
70% similarity in the Zn fingers (Tunyaplin et al., 2000). The deletion allele tm548, which
was isolated by a reverse genetic approach (National Bioresource Project), has an 810
bp deletion, removing part of exon 3 and part of intron 3 and may result in a truncated
BLMP-1 protein containing the first 254 amino acids of BLMP-1 and 17 amino acids
encoded by the third intron.
To determine if and to what extent BLMP-1 may participate in the hypoxic induction of
other transcripts we treated blmp-1 mutant worms with hypoxia and surveyed the
expression of five other HIF-independent hypoxic transcripts described by Shen et al.
(2005). As expected, control animals responded robustly to hypoxic challenge through
upregulation of transcript. Additionally, in each case, mutation of hif-1 failed to
extinguish this response (Figure 4.7.b); however, while icl-1 and F44E5.5 were entirely
unaffected in this background, mnk-1, mod-5, and zip-1, exhibited somewhat muted,
though still significant, response profiles, suggesting that the hypoxic regulation of these
transcripts may entail a combination of HIF- and non-HIF-mediated events. Of the three
clones that were effective at mitigating GFP signal in both cobalt chloride and unaffected
in this background, mnk-1, mod-5, and zip-1, exhibited somewhat muted, though still
significant, response profiles, suggesting that the hypoxic regulation of these transcripts
may entail a combination of HIF- and non-HIF-mediated events. These results differed
from those obtained in the blmp-1 mutant background, where all hypoxic
responsiveness was eliminated (Figure 4.7.b).
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Figure 4.7.b. Hypoxic regulation of transcripts by BLMP-1 is HIF-independent
A – I Total mRNA was collected from wild type animals and blmp-1(tm548) mutants (A)
or from wild type animals, hif-1(ia4) mutants, and blmp-1(tm548) mutants (B-I) after
incubation in normoxia or hypoxia (0.1% O2) for 12 hours. The expression levels of
HIFindependent genes F45D3.4 (A), icl-1 (B), F44E5.5 (C), mnk-1 (D), mod-5 (E), and
zip-1 (F) were analyzed by qRT-PCR. Normalized values are the average of at least
three biological replicates. Error bars are SEM. ** indicates a p-value < 0.01 and *
indicates a p-value < 0.05. A student’s t-test was used to determine significance.
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4.8: blmp-1 does not mediate expression of a distinct subset of HIF-1-dependent
hypoxia response genes
We assayed known HIF-dependent hypoxic transcripts, and found that the hypoxic
expression of nhr-57, egl-9, and fmo-12 was greatly affected (Figure 4.8), if not
eliminated, in the hif-1 mutant, similar to published data (C. Shen et al., 2005). In
contrast—and in line with BLMP-1 acting independently from HIF-1—the effect of blmp1 mutation on the hypoxic expression of these same transcripts was significantly less
impactful, and in the case of fmo-12 had no effect on hypoxic expression. These
collective results demonstrate that BLMP-1 is essential for the hypoxic regulation of a
unique subset of hypoxic response genes that differs from those regulated by HIF-1.
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A)

B)

C)

Figure 4.8. BLMP-1 does not regulate HIF-dependent genes Total mRNA was
collected from wild type animals, hif-1(ia4) mutants, and blmp-1(tm548) mutants (A-C)
after incubation in normoxia or hypoxia (0.1% O2) for 12 hours. The expression levels
HIF-dependent genes nhr-57 (A), egl-9 (B), and fmo-12 (C) were analyzed by qRTPCR. Normalized values are the average of at least three biological replicates. Error
bars are SEM. ** indicates a p-value < 0.01 and * indicates a p-value < 0.05. A student’s
t-test was used to determine significance.
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4.9. blmp-1 mutants are sensitive to hypoxia.
To further investigate the effects of BLMP-1 in HIF-independent hypoxic responses, we
evaluated if blmp-1 mutants are sensitive to hypoxia treatment. Two different types of
hypoxia lethality assays were conducted.
In the severe hypoxia treatment, wild type, hif-1 mutants, blmp-1 mutants, and hif-1;
blmp-1 double-mutant embryos are treated with 0.1% hypoxia and scored for embryos
that made it to adulthood. The number of adults that make it to adulthood is counted
and a percentage value of number surviving compared to number treated (hypoxia/
normoxia) is plotted. As seen in Figure 4.9, only 60% of blmp-1 mutants make it to
adulthood compared to about 95% of the wild type. The hif-1 mutants and the hif-1;
blmp-1 double mutants do not survive this treatment.
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Figure 4.9.a. blmp-1 mutants are sensitive to severe hypoxia Wild type, hif-1(ia4),
blmp-1, and hif-1;blmp-1 double mutant embryos were counted and treated to 0.1%
hypoxia for 24 hours. Embryos were allowed to proceed to adulthood in normoxia. The
number of adults that make it to adulthood is counted and a percentage value of
number surviving compared to number treated (hypoxia/ normoxia) is plotted
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We also wanted to evaluate the sensitivity of blmp-1 mutants in continuous hypoxia and
for these experiments, we collaborated with Dr Pamela Padilla for conducting hypoxia
sensitivity assays under continuous hypoxia conditions. We challenged embryos of
control animals, hif-1 mutants, blmp-1 mutants, and hif-1; blmp-1 double-mutants, which
were allowed to develop for four days in normoxia or hypoxia. As expected, the control
and hif-1 mutants developed equally well under normoxic conditions, while blmp-1
mutants and hif-1; blmp-1 double-mutants displayed a mildly penetrant lethal phenotype
(Figure 4.9.b). In contrast, only 62.5% of control animals survived in 0.5% O 2; however,
among surviving animals, the vast majority (~75%) were able to progress to adulthood,
which was 48% of all the embryos surveyed. This was different from hif-1 mutants and
hif-1; blmp-1 double-mutants, which showed no progression and no survivability in
hypoxia. Importantly, blmp-1 mutants were also severely affected by hypoxia; no
animals matured to adulthood over the 4-day challenge. Further, even amongst the
reduced number of surviving blmp-1 mutants, less than half progressed out of the L1/L2
stage. Hence, blmp-1 mediates transcriptional responses in hypoxia and is required for
proper survival in hypoxia. Next, seeing that the hif-1 and hif-1; blmp-1 double-mutants
show no survivability in hypoxia, we wanted to look at a less severe hypoxia
concentration at which HIF-1 is not known to be stabilized. Indeed, we saw an
increased sensitivity phenotype for blmp-1 mutants and hif-1; blmp-1 double-mutants
under the less severe hypoxic treatment regimen of 2% oxygen (Figure 4.9.c). These
results demonstrate that BLMP-1 is essential for normal developmental progression in
hypoxia and that loss of both HIF-1 and BLMP-1 renders the animal more sensitive to
hypoxic insult than the single mutants.
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Figure 4.9.b. blmp-1 mutants are sensitive to continuous hypoxic exposure
15-20 adult animals (wild type, hif-1 mutants, blmp-1 mutants, or hif-1; blmp-1 doublemutants) per trial were allowed to lay eggs on an OP50-seeded NGM plate for 1-2 hours.
The embryos were placed in either normoxia or hypoxia (0.5% O2) at 20°. After 4 days,
surviving animals were scored for developmental progression as adults, L3/L4 larvae, or
L1/L2 larvae. Note that hypoxia slows development, resulting in young adults, whereas in
normoxia adults are 1 day old and gravid. For each genotype and condition, 4
independent experiments were performed with a total of 200-350 worms. Error bars are
SEM.

Figure 4.9.c. blmp-1; hif-1 double mutants are sensitive to less harsh hypoxic
exposure The experiment was conducted exactly as Figure 3.9.b, but at 2% hypoxia
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4.10: blmp-1 mRNA and protein levels do not change in hypoxia
Since BLMP-1 plays a critical role in hypoxia, I wondered whether blmp-1 expression is
modified in hypoxia. Wild type and hif-1 mutants were treated to hypoxia and the blmp-1
expression level was measured by qRT-PCR. As seen in Figure, there is no apparent
change in the levels of blmp-1 upon hypoxia treatment. Since we did not have access to
Ce-BLMP-1 antibody, I used a blmp-1 overexpression system with an integrated blmp1::gfp transgene and looked for changes in blmp-1::GFP levels following hypoxia
treatment. The blmp-1::GFP transgene is expressed in the nucleus in neurons, tail, and
vulva (Niu et al., 2011). Hypoxia treatment did not alter the localization of the transgene,
although more detailed studies may be necessary considering this is an overexpression
system and BLMP::GFP may not regulated like endogenous BLMP-1. In conclusion, it
appears that the message and protein levels of BLMP-1 are not altered in hypoxia.
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A)

B)

Figure 4.10. BLMP-1 levels do not change in hypoxia The potential
hypoxic regulation of blmp-1 transcript was assayed by qRT-PCR from total
RNA collected from adult wild type or hif-1(ia4) mutant animals treated in
normoxia or hypoxia (0.1% O2) for 6hours (A). The hypoxic regulation of
BLMP-1 protein was assayed using an integrated blmp-1::gfp transgene
(wgIs109, Sarov et al 2012) that was treated to 6 hours of hypoxia. Wild type
with no transgene was used as a control (B).
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4.11. BLMP-1 localizes to promoter of HIF-independent gene
Apart from its non-dependency on HIF-1 and lack of EGL-9 regulation, the mechanisms
supporting blmp-1-dependent control of hypoxic transcription are unknown. As an initial
step toward uncovering a possible mechanism, we looked at several aspects of BLMP-1
biology in hypoxia. As mentioned earlier, we determined that blmp-1 expression
remains unchanged in hypoxia; this is the case in control animals and hif-1 mutants
(Figure 5A). Hence, transcriptional upregulation cannot account for a change in BLMP-1
activity in hypoxia. Further, chromatin immunoprecipitation (ChIP) was used to assess if
hypoxic treatment altered recruitment of a GFP-tagged version of BLMP-1 (NIU et al.
2011) to the F45D3.4 promoter. These results were not a product of non-specific
antibody binding, since no enrichment was observed in the wild type background
(Figure 4.11). Although we found a significant enrichment of BLMP-1-GFP at the
proximal F45D3.4 promoter sequence, our results indicate the localization is unaffected
by hypoxia treatment (Figure 4.11). The previous data suggested that changes in
oxygen status are relayed to pre-localized BLMP-1 at respective loci, which
subsequently trigger increased transcriptional activity. Consistent with this idea,
additional ChIP experiments demonstrated a surge in the acetylation of histone H3
following hypoxia treatment (Figure 4.11), indicating an oxygen-sensitive increase in
chromatin decondensation in the same region bound by BLMP-1-GFP. Importantly,
similar increases were not observed in the blmp-1 mutant (Figure 4.11), a result that
aligns with a failure to upregulate transcription.
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Figure 4.11. BLMP-1 mediates hypoxic-induced histone acetylation Chromatin
immunoprecipitation was used to monitor the effects of 0.1%O2 hypoxia for 6 hours on
BLMP-1 localization (A&B) or histone H3 acetylation (C&D) at the F45D3.4 promoter.
F45D3.4 promoter sequences were enriched in the OP109 background by IP of BLMP-1GFP with anti-GFP antibodies compared to control IgG antibodies, but results were
unaffected by hypoxic treatment (A). No enrichment of signal is seen with the anti-GFP
antibody over IgG alone in the wild type in normoxia or hypoxia (B) Acetylation of the
F45D3.4 promoter increased in a hypoxia-dependent manner in the wild type background
(C), but no such increase was apparent in blmp-1(tm548) mutants (D), by ChIP using antiacetylated histone H3 antibodies versus IgG control antibodies. Values are the average of at
least 3 biological replicates and are plotted as a factor of percent input. Fold-change
increases between control IgG antibody and anti-AcH3 or anti-GFP signals are shown. Error
bars are SEM. ** indicates a p-value < 0.01 and * indicates a p-value < 0.05. Statistical
insignificance between measurements is noted by n.s. One-way and two-way ANOVA was
used to compare results within and between groups with a post-hoc Tukey HSD test (A-D).
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4.12: Upstream modulators of blmp-1-dependent hypoxia response
We also conducted a candidate screen of other known regulators of the HIF-1 pathway
in hypoxia, including vhl-1, rhy-1, and swan-1, as well as HIF-1α dimeric partner arnt-1
or HIFβ. To determine if the 3kb-F45D3.4::GFP reporter was regulated similarly to HIF-1
in normoxia by oxygen-dependent hydroxylation via the HIF prolyl hydroxylase EGL-9
(Epstein et al., 2001), we further assayed the reporter in egl-9; hif-1 double-mutants
(Figure 4.12). We found that the behavior of the reporter was unchanged in normoxia
and indistinguishable from the hypoxic activity observed in the control background. This
suggests that the oxygen sensor in the HIF-1-independent pathway is different from that
of the canonical pathway.
We also looked at the effects of knockdown of chromatin remodeling factors involved in
stress responses. Barring lin-40 (described later) and hda-1 the other candidate genes
did not mediate the HIF-independent response. The fact that hda-1 was isolated by a
candidate screen is interesting, because a recently published study independently
isolated hda-1 to be important in the regulation of HIF-independent gene hsp16.1 (J.
Lee & Lee, 2013). hda-1 is responsible for the deacetylation of lysine residues on the Nterminal part of the core histones (H2A, H2B, H3 and H4) and is an essential gene. The
design of my screen, which looked at mediators of the hypoxia response from L1 to
adult, permitted me to explore the role of hda-1. This result coupled with the
identification of lin-40 strongly suggest that chromatin remodeling factors are involved in
the regulation of HIF-independent genes in hypoxia.
Next, I looked at effects of knockdown of guanylyl cyclases that sense changes in
oxygen concentration in C.elegans (Gray et al., 2004). Knockdown of gcy-31 but not
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gyc-33 and gcy-35 resulted in a 48% reduction in 3kb-F45D3.4:GFP levels. Only genes
whose knockdown resulted in at least 75% reduction in 3kb-F45D3.4:GFP levels were
considered positive hits in my screen; however, further studies exploring the role of gcy31 in the HIF-independent hypoxia response may be necessary. In conclusion, the
BLMP-1 dependent hypoxia response does not seem to be regulated by some of the
classic players of the HIF pathway; however, this candidate screen helped identify some
potential regulators that merit further study.
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Figure 4.12. Candidate screen of potential regulators of the hif-1-independent
hypoxia response: A) The 3kb-F45D3.4:GFP reporters were fed RNAi of genes involved
in the HIF-1 pathway, chromatin remodeling factors involved in stress responses, and
guanylyl cyclases. Percentage of reporters showing GFP expression upon hypoxia
treatment was scored. n = 80 and the study was in duplicate. The red boxes indicate
potentially interesting hits. B) Expression of GFP in wild type, hif-1(ia4) mutant, and egl9(sa307); hif-1(ia4) double mutant backgrounds carrying the 3kb-45D3.4::GFP construct
after treatment in normoxia and hypoxia for 12 hours. Scale bars indicate 10 μm.
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4.13: blmp-1 and ER stress
As mentioned earlier, hypoxia can induce ER stress and activate the UPR through 3
signaling pathways mediated by ER sensors IRE1-XBP-1, PERK-eIF2-ATF4 and ATF6
(Ron & Walter, 2007). The transgenic transcriptional reporter Phsp-4::GFP(zcIs4) has
been shown to be a reliable reporter of activation of the UPR in C. elegans (Calfon et
al., 2002). The hsp-4 gene encodes a homologue of mammalian BiP/GRP78, a hypoxia
response gene, and its induction reflects the activation of the IRE-1–XBP-1 branch of
the UPR (Mao & Crowder, 2010; Roll et al., 1991). The activation of HSP-4/ BiP by
XBP-1 in hypoxia is HIF-independent and I hypothesized that BLMP-1 may play a role
in the HIF-independent ER stress pathway in hypoxia.

Phsp-4::GFP reporters were fed control RNAi and blmp-1 RNAi and then treated with
hypoxia. I found that hypoxia induced the expression of Phsp-4::GFP fed control RNAi,
consistent with the expectation that hypoxia would elicit the UPR in C. elegans.
Interestingly, the reporters fed blmp-1 RNAi showed greater induction of Phsp-4::GFP
upon hypoxia treatment than control RNAi worms (Figure 4.13.a), suggesting that loss
of BLMP-1 causes significant induction of the ER stress pathway in hypoxia. We
confirmed the hypoxia-induced activation of the endogenous hsp-4 mRNA and spliced
xbp-1 levels by qRT–PCR and saw that the expression levels of both hsp-4 and spliced
xbp-1 were significantly increased in hypoxia.
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Figure 4.13.a. Loss of BLMP-1 enhances ER stress in hypoxia ER stress reporter
Phsp-4::GFP that was fed blmp-1 RNAi showed marked increase in GFP levels compared
to reporters fed control RNAi (A). Total mRNA was collected from wild type animals and
blmp-1(tm548) mutants after incubation in normoxia or hypoxia (0.1% O2) for 4 hours.
The expression levels of hsp-4 (B) and spliced xbp-1 (C) were analyzed by qRT-PCR.
Normalized values are the average of at least three biological replicates. Error bars are
SEM. ** indicates a p-value < 0.01 and * indicates a p-value < 0.05. A student’s t-test was
used to determine significance.
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We next asked if BLMP-1 is required for resistance to tunicamycin, an antibiotic that
inhibits the N-glycosylation of proteins and thereby increases the load of misfolded
proteins transiting the endoplasmic reticulum (Merksamer et al. 2009). In C. elegans,
tunicamycin reliably induces the UPR, presumably through its known activity to increase
protein misfolding (Calfon et al., 2002).

I tested two concentrations of tunicamycin on wild type and blmp-1 mutants (Figure
4.13.b). Following treatment with 1 μg/ml of tunicamycin, nearly 85% of the first larval
stage (L1) of the wild-type strain developed to at least the fourth larval stage (L4) in this
assay, compared to their growth and development on the non-treated plates. In
contrast, the blmp-1 mutant on tunicamycin exhibited severely attenuated larval
development and growth, as measured by the rate of progression between molts, size
of larvae, and ability of larvae to reach the L4 stage by 72 h. Following a harsher
treatment of tunicamycin at 5 ug/ml, 60% of the wild type developed to at least the L4
stage, but almost 70% of the blmp-1 mutants did not survive the treatment. These data
implicate a specific and protective role for BLMP-1 during ER stress.
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Figure 4.13.b. Loss of BLMP-1 increases susceptibility to ER stress by tunicamycin.
Wild type and blmp-1 mutant worms of the L1 larval stage were treated to either control
DMSO or tunicamycin at 1 ug/mL (A) or 5 ug/mL (B). L4/ adults that survived the
treatment 72 hours later were counted. * indicates a p-value < 0.05. A student’s t-test was
used to determine significance. Experiments were conducted in triplicate.
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4.14: blmp-1 and collagen
The cuticle is a collagenous extracellular matrix that is synthesized by the hypodermis,
an underlying ectodermal cell layer that surrounds the body of the animal. Cuticle
synthesis occurs five times during development, once at the end of embryogenesis prior
to hatching, and then prior to molting at the end of each larval stage. Collagen
biosynthesis is a complex process, and genes vital for cuticle formation are induced
prior to every molting cycle.

A previous microarray study reported that genes governing collagen and extracellular
matrice processes were misregulated in hypoxia (C. Shen et al., 2005). Of the genes
induced in hypoxia were the phy-2 prolyl 4-hydroxylase α subunit gene and the bli3 NADPH oxidase, which have central roles in collagen synthesis (Edens et al., 2001;
Myllyharju, 2003; C. Shen et al., 2005). Moreover, genes encoding 4 predicted
extracellular molecules with lectin domains (ptr-8, C31G12.2, F35D11.10, and
F47C12.2) and one predicted chitin-binding protein (K04H4.2) were also differentially
regulated in hypoxia.

Reduced expression of blmp-1 leads to morphological defects like a dumpy phenotype
and formation of a weak cuticle (Zhang et al. 2012). Dil staining of the cuticle (Schultz &
Gumienny, 2012) showed that compared to wild type, blmp-1 mutants have a defect in
their annuli, the circumferential structure imparting ridges in outer layers of the cuticle.
The bmlp-1 cuticle appears fractured and unorganized compared to the wild type. This
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phenotype is typical of mutants of other collagen encoding genes like dpy-2 and dpy-3
(Myllyharju & Kivirikko, 2004).

I hypothesized that BLMP-1 targets a set of molting and cuticle-related genes in C.
elegans in hypoxia. I focused on two HIF-1-independent genes from the previous study
that are involved in collagen formation: bli-3 and ptr-8 (C. Shen et al., 2005). BLI-3 is a
major cuticle enzyme and is required for dityrosine cross-linking of collagen. Loss of bli3 is not lethal, but results in loss of cuticular integrity (Edens et al., 2001). ptr-8 is a
member of the patched related family of transmembrane glycoproteins and is important
for collagen formation and molting (Fielenbach & Antebi, 2008).

As seen in Figure, bli-3 and ptr-8 are induced in hypoxia in wild type and hif-1 mutants,
while loss of blmp-1 abrogates this induction, suggesting that bli-3 and ptr-8 are
downstream of blmp-1. If blmp-1 does regulate these genes in hypoxia, loss of function
mutants of bli-3 and ptr-8 should phenocopy blmp-1’s phenotype in hypoxia. Indeed, bli3 mutants are sensitive to hypoxia treatment: a known number of wild type and bli-3
mutant embryos were treated with hypoxia and the number of embryos that made it to
adulthood were counted. As seen in Figure 4.14, similar to blmp-1 mutants, about 60%
of bli-3 mutants survive hypoxia treatment. These results strongly imply that collagen
formation is important in hypoxia and that BLMP-1 may be regulating the expression of
critical collagen formation genes like bli-3. Future studies looking at hypoxia phenotypes
of blmp-1; bli-3 double mutants are warranted.
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Figure 4.14. BLMP-1 mediates collagen formation genes in hypoxia A) DiI staining of
wild type and blmp-1 mutants shows marked changes in the cuticular structure B, C) qRTPCR analysis of wild type, hif-1, and blmp-1 mutants for HIF-independent genes bli-3 (B)
and ptr-8 (C) D) Hypoxia lethality assays of wild type and bli3-/- mutant eggs treated to 0.1%
hypoxia for 24 hours, followed by incubation in normoxia. The percentage of number of
adults relative to the number of embryos treated is plotted. * indicates a p-value < 0.05. A
student’s t-test was used to determine significance. Experiments were conducted in
triplicate.
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4.15: LIN-40 and the HIF-independent hypoxia response
The chromatin remodeling factor lin-40 was isolated by my screen as a HIFindependent mediator of the hypoxia response. Knockdown of lin-40 abrogated GFP
expression in the HIF-independent reporter, both in hypoxia as well as cobalt chloride
treatments. The lin-40 gene encodes a protein that is homologous to MTA1 and MTA2
in mammals, which were identified as components of the NuRD complex (Solari &
Ahringer, 2000). MTA1 levels are increased in breast and ovarian cancer cells
(Murakami, Kaul, & Robertson, 2014). In hypoxia, MTA1 recruits HDACs to stabilize
HIF-1α to promote tumor growth and metastasis (Yoo, Kong, & Lee, 2006). In C.elegans
LIN-40 was recently shown to promote stress resistance and longevity in a circuit that
involves the germline and the insulin pathway (Zimmerman and Kim 2014).
lin-40 is an essential gene and is required for proper vulval cell fate specification and
morphogenesis (Solari & Ahringer, 2000; Zimmerman & Kim, 2014). Worms fed lin-40
RNAi are healthy suggesting that the knockdown of lin-40 is not complete. Wild type
and hif-1(ia4) worms were fed lin-40 RNAi and qRT-PCR was conducted to determine
the level of lin-40 knockdown. The RNAi treatment reduced lin-40 RNA levels only by
40% in both wild type and hif-1(ia4) mutants. To verify that lin-40 does regulate the
expression of HIF-independent gene F45D3.4, I conducted a qRT-PCR analysis of wild
type and hif-1 mutant worms fed lin-40 RNAi from larval stage L1 and treated with
hypoxia in adulthood. Indeed, qRT-PCR analysis showed that lin-40 knockdown
abrogates the induction of F45D3.4 in both wild type and hif-1 mutants. To further
explore if lin-40 contributes to the hypoxia response, we conducted a hypoxia lethality
assay on wild type and hif-1 mutants that were fed lin-40 RNAi for one generation.
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Embryos, collected from progeny whose mothers were fed lin-40 RNAi, were counted
and treated with normoxia and hypoxia for 24 hours. The number of embryos that made
it to adulthood were counted and the percentage of embryos treated that reached
adulthood was plotted. As seen in Figure 4.15, in hypoxia, knockdown of lin-40 in the
wild type resulted in 40% reduction in embryo viability compared to wild type fed control
RNAi (L4440), which is considerable since lin-40 RNAi treatment reduced lin-40 mRNA
levels to about 50%. In conclusion, these results show that the regulation of HIFindependent gene F45D3.4 involves chromatin remodeling factor LIN-40 and that lin-40
may play a role in hypoxia survival.
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Figure 4.15: LIN-40 plays a role in the HIF-independent response A) qRT-PCR
showing lin-40 mRNA knockdown in wild type and hif-1 mutants fed lin-40 RNAi. B) qRTPCR analysis showing F45D3.4 expression levels in wild type and hif-1 mutant worms fed
lin-40 RNAi. C) Embryos from wild type and hif-1 mutants fed control RNAi and lin-40 RNAi
treated to 0.1% hypoxia for 24 hours * indicates a p-value < 0.05.
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5. Discussion
All large organisms face the fundamental physiological challenge of matching oxygen
supplies to the needs of respiring tissues. In higher animals, specialized organs
facilitate oxygen delivery, and the lungs, heart, blood and vascular system are all
devoted to this purpose. The coordination of these complex homeostatic systems
requires robust mechanisms for detecting and responding to imbalances in oxygen
homeostasis. The conserved HIF-1 complex regulates the expression of a broad set of
genes that are important for metabolism, vascularization, and cell survival across
species (Semenza 2011). HIF, expressed very widely in mammalian cells (Wang &
Semenza, 1993; Firth et al. 1994), is conserved in simpler animal species that lack
erythropoietin, red blood cells, and specialized oxygen-delivery organs (Nagao et
al. 1996; Loenarz et al. 2011). A recent study on HIF binding to DNA has now revealed
that more than 500 genes are directly regulated by HIF in a given cell line (Mole et
al. 2009; Xia et al. 2009; Schödel et al. 2012b). These primary targets will initiate
secondary targets, so that the overall complexity of activating the HIF response and
hence, the hypoxia response is enormous.

The total hypoxic response, however, is not entirely dependent on the HIF pathway.
Although HIF-independent hypoxia-induced activities have also been identified in other
organisms and HIF-1α is dispensable for hypoxic upregulation of a host of transcripts in
mammalian cells, these pathways remain poorly understood. These results suggest that
HIF-independent hypoxic signaling mechanisms may act in concert with, or even
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supplant, the HIF response pathway in a context-dependent manner. Further support of
this idea is evident in the expression of Alas2, the rate-limiting enzyme for heme
production. Alas2 has been identified as a HIF-dependent and a HIF-independent
hypoxia-regulated gene in mammals. In C. elegans, there is clear evidence of HIFindependent responses in hypoxia. Shen et al. (2005) showed that out of 110 hypoxiainduced genes, 47 were induced in a HIF-independent manner. Additionally, C. elegans
can survive for about 24 hours in anoxic conditions and this response does not require
hif-1; instead, this ‘suspended animation’ response is mediated by the spindle
checkpoint protein SAN-1 in embryos and the ceramide synthase HYL-2 in adults
(Padilla et al., 2002; Nystul et al., 2003; Miller and Roth 2009). Further, Lee and Lee
(2013) described the role of the chromatin-remodeling factor NURF-1 in regulating the
expression of a novel HIF-1-independent protein, heat shock protein HSP-16.1 (Lee and
Lee 2013).

5.1: HIF-independent screen reveals interesting candidates
In this study, through a targeted RNAi approach, we screened for transcription factors
that mitigated hypoxic induction. Eight factors were identified in the cobalt chloridebased screen, and three of these were found to be regulated by both hypoxia and cobalt
chloride. BLMP-1, which has been discussed in depth in this study, regulates several
HIF-independent transcripts in hypoxia and loss of blmp-1 makes worms sensitive to
hypoxia insult. LIN-40, also discussed previously, is an interesting target because of the
known functions of its homolog MTA-1 in hypoxia.
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The other positive hit was tbx-38, a T-box transcription factor that functions with Notch
to mediate early cell fate decisions; at the 12-cell stage, Notch and tbx-38 interact to
render the mesodermal fate to AB.a descendant cells (Good et al., 2004). Interestingly,
tbx-38 was also identified as a HIF-independent gene in an independent microarray
study, thereby validating the robustness of the screen I conducted (C. Shen et al.,
2005). The isolation of a mediator of differentiation is important, considering that some
of the defined developmental roles of hypoxic response in low oxygen are stimulation of
the proliferation of CNS precursor cells (Studer et al., 2000) and neural crest stem cells
(Morrison et al., 2000) and inhibition of adipocyte differentiation (Yun et al., 2002). The
molecular processes underlying these effects are less understood; however, recent
studies have highlighted the importance of the synergy between hypoxia and Notch
pathways for inhibiting differentiation of precursor cells during early stages of
embryogenesis (Gustafsson et al., 2005). Hypoxia activates Notch, which physically
interacts with HIF-1 and HIF-independent gene FIH-1 to activate downstream target
genes to maintain the undifferentiated cell state (Cejudo-Martin & Johnson, 2005).
Moreover, given that the PRDM mediates the activation of Notch target genes, it will be
interesting to explore the role of the Notch pathway in HIF-independent mediated cell
differentiation, particularly with respect to tbx-38 and blmp-1 (Hohenauer & Moore,
2012).

The 4 other hits were only isolated from the cobalt chloride screen and although the
phenotype could not be confirmed in the hypoxia chamber, the potential role of these
hits in hypoxia is interesting. To faithfully understand the difference in the regulation of

82
these genes in cobalt chloride as opposed to hypoxia, it may be necessary to modify the
treatment protocol to include other stages of the worm (Vengellur & LaPres, 2004).

For example, one of the hits isolated from the cobalt chloride treatment not for hypoxia
is npp-12, which encodes a conserved membrane protein gp120 of the nuclear pore
complex. In C.elegans, NPP-12 is phosphorylated by CDK-1/cyclin B and is important
for the depolymerization of lamin and required for nuclear envelope break down (NEBD)
(Padilla et al., 2004). Embryos treated with 0.1% hypoxia go into a HIF-independent
state called suspended animation, in which the rate of energetically expensive
processes is reduced and the occurrence of damaging events like aneuploidy is
prevented (Nystul & Roth, 2004). In hypoxic embryos, the blastomeres arrest in
prophase and nuclear envelope break down is halted to prevent the transition to
prometaphase; however, embryos mutant for nucleoporin genes are unable to halt and
are unable to survive the hypoxia insult (Padilla et al., 2004). Hence, hypoxia influences
the cell cycle machinery in C. elegans and it will be interesting to see how npp-12
mutant embryos fare in severe hypoxia.

The other positive hit from the cobalt chloride related screen is taf-11.2, which encodes
a subunit of TFIID, which comprises the TATA-binding protein (TBP) and TBPassociated factors (TAFs). This is interesting because it has been previously shown that
HIF1α recruits TFIID to the promoters of hypoxia responsive genes glut-1 and
phosphoglycerate kinase 1 (Okino, Chichester, & Whitlock, 1998).
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The roles of a GATA transcription factor elt-3, which regulates everal aging genes
(Zimmerman & Kim, 2014), and nuclear hormone receptors nhr-31 and nhr-89 in
hypoxia signaling need further exploration.

5.2: BLMP-1 and the hypoxia response
We identified the zinc finger protein BLMP-1 as a mediator of the HIF-independent
response. Until very recently, the role of nematode BLMP-1 was not clearly defined. In a
previously published genome-wide RNAi screen in C. elegans, blmp-1 was found to
affect male tail tip morphogenesis and loss of blmp-1 was found to result in precocious
retraction of the male tail tip (Nelson et al., 2011). Moreover, blmp-1 was shown to
modulate adult lifespan and cuticle morphogenesis (Samuelson et al., 2007; Greer et
al., 2010; Zhang et al., 2012). Recently, it was shown that blmp-1 is a heterochronic
gene controlling epidermal and gonadal maturation and that it is targeted by an E3
ubiquitin ligase DRE-1. This BLMP-1/ DRE-1 module controls dauer formation, molting,
and longevity in C. elegans (Horn et al., 2014).

Mammalian BLIMP-1 is extensively studied in different cellular contexts: BLIMP1 is
necessary and sufficient to drive terminal differentiation of B cells into antibodysecreting plasma cells and also governs various cell fate decisions, including primordial
germ cell specification and skin differentiation, generally working as a transcriptional
repressor (Horsley et al., 2006; Ohinata et al., 2005; Turner et al., 1994; Shapiro-Shelef
et al., 2003). Moreover, PRDM1/BLIMP-1 is a well-known regulator of plasma cell
differentiation and is an important regulator of T cells, which can be dramatically
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influenced by the dynamic and sometimes hypoxic microenvironments that are known to
affect T cell mediated cytokine production and inflammatory responses. Given that C.
elegans BLMP-1 and mammalian BLIMP-1 show striking domain conservation
(Tunyaplin et al., 2000) and the conserved nature of HIF- and non-HIF-mediated
hypoxic signaling pathways in general, it will be interesting to determine if the
mammalian equivalent of C. elegans BLMP-1 fulfills similarly important roles in
mammalian hypoxic responses.

5.3: BLMP-1 and downstream effectors in hypoxia
Because BLMP-1 is a transcriptional regulator, a natural question arising from our
studies is, what are the BLMP-1-regulated targets important for hypoxia adaptation?
Through qRT-PCR, I identified a few targets of BLMP-1. The regulation of icl-1 and
F44E5.5 in hypoxia seem to be entirely dependent on BLMP-1. icl-1 encodes an
isocitrate lyase that is important in the glyoxylate pathway for catalyzing the cleavage of
isocitrate to succinate and glyoxylate. Although a role for icl-1 in mammals has not been
extensively studied, the glyoxylate pathway is of importance to plants and bacteria as it
enables the utilization of lipid for generating glucose. Interestingly, icl-1 is preferentially
uregulated in hypoxia and essential for the survival of Mycobacterium in hypoxia (Eoh &
Rhee, 2013). Further, F44E5.5 is a chaperone protein and a member of the hsp70
family of heat shock proteins. The precise role of F44E5.5 is not known, but the hsp70
family of proteins are crucial for protecting cells from ER stress-induced apoptosis. mnk1, mod-5, and zip-1, exhibited somewhat muted, though still significant, response
profiles. mnk-1 encodes the C. elegans ortholog of the Mnk MAP kinase-interacting
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kinase, while MOD-5 is a serotonin transporter. Moreover, a CHIP-SEQ study
conducted in the first larval stage of worms in normoxia showed that BLMP-1 binds to
the promoters of F45D3.4, F44E5.4, bli-3, and zip-1 (Niu et al., 2011).

However, to identify the whole range of transcripts that are regulated in hypoxia, RNAseq and ChIP-seq experiments should be conducted in wild type and blmp-1 mutants
treated with hypoxia. This would be interesting considering a recent RNA-seq
conducted on blmp-1 mutants in normoxia showed BLMP-1 to target a set of molting
and cuticle-related genes in C.elegans, consistent with my observation of misregulation
of collagen formation genes in blmp-1 mutants (discussed later).

5.4: BLMP-1 and HIF
BLMP-1 actions in hypoxia do not require HIF-1, but our data does not exclude that it
acts in concert with it. For example, loss of hif-1 can dampen, but not extinguish hypoxic
induction of mod-5 and zip-1, while loss of blmp-1 eliminates it altogether. This suggests
that BLMP-1 acts as a hypoxic competence factor in certain contexts that provides a
path for further response by other factors, including HIF-1. This is not surprising,
considering we have previously shown in Drosophila that ERR mediates HIF-dependent
hypoxic responses in conjunction with HIF-1 as well as independently of HIF-1. In this
respect, the ability of a BLMP-1-mediated non-HIF-dependent pathway to work apart
from and in conjunction with the HIF pathway in C. elegans should be explored further
(LI et al. 2013). HIF-1 transcripts levels were not altered in blmp-1 mutants nor were
blmp-1 transcript levels in hif-1 mutants.
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blmp; hif-1 double mutant eggs are unable to survive severe hypoxia insult, similar to
hif-1 mutants. Interestingly, blmp; hif-1 double mutant eggs treated to a more permissive
hypoxia treatment of 2% show a synthetic phenotype and are more sensitive to the
treatment than the single mutants alone. It is likely that the mutations in two critical
genes overburdened the worm and affected its ability to survive stress. However, it is
also possible that both blmp-1 and hif-1 function redundantly or are required for the
same hypoxia survival pathway. Indeed it will be interesting to determine the
transcriptional profile of the blmp-1; hif-1 double mutants, especially in temperaturecontrolled hypoxia chambers. I attempted to conduct qRT-PCR experiments on the
double mutants, but the response varied greatly in response to temperature fluctuations.

5.5. BLMP-1 and epigenetic modifications
In mammals, a variety of BLIMP-1 targets have been identified across tissues. For
example BLIMP-1 resides at the c-myc promoter to block its transcription, thereby
preventing proliferation during B cell maturation (Lin et al., 1997). BLIMP-1 is thought to
switch-off whole gene expression programs such as mature B cell programs during B
cell differentiation on the one hand and somatic programs during primordial germ cell
specification on the other hand (Vincent et al., 2005; Ohinata et al., 2005; Shaffer et al.,
2002). How BLIMP-1 fulfills these highly context-specific functions remains poorly
understood. In particular, germ cell development involves major epigenetic remodeling,
which strongly relies on BLIMP-1 function (Surani, Hayashi, & Hajkova, 2007). BLIMP-1
harbors a SET domain, but BLIMP-1 itself bears no intrinsic enzymatic activity (Ancelin
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et al., 2006; Dillon et al., 2005). Instead, it cooperates with epigenetic regulators to
control transcription and epigenetic remodeling (Surani et al., 2007)(Su et al., 2009;
Ancelin et al., 2006; Yu et al., 2000; Gyory et al., 2004). Therefore, a distinct set of
cofactors present in different tissues might allow BLIMP-1 context-specific action.
Moreover, one could speculate that also in C. elegans BLMP-1, mediates epigenetic
regulation for hypoxia adaptation. It is intriguing to note that BLMP-1-dependent
increases in histone acetylation at the F45D3.4 promoter during hypoxia may occur in
conjunction with the pro-longevity factor LIN-40, one of the other two positive hits
identified in our screen. As mentioned earlier, LIN-40 is an essential component of the
nucleosome remodeling deacetylase (NuRD) complex (Johnsen and Baillie 1991; Solari
et al. 1999) and is critical for coordinating the hypoxia response with HIF-1 in ovarian
and breast cancer cells. Interestingly, unpublished results from our lab are consistent
with LIN-40 and BLMP-1 acting together through direct interaction in stress conditions to
regulate common targets for dauer formation (M. Hyun personal communication).
Indeed, precisely how the cobalt chloride or hypoxia insult affects BLMP-1 to alter
transcriptional output in C. elegans is interesting and will require more investigation.

5.6 Investigation of Upstream Regulators
Another key question is what are the critical upstream regulators of BLMP-1 protein
stability? In particular my findings that BLMP-1 levels are constant upon hypoxia
treatment, point to other cofactors that contribute to BLMP-1 regulation. Their
identification may provide information on coordination of the hypoxia response across
species. Interestingly mammalian BLIMP-1 has recently been shown to be sumoylated
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by SUMO-1 at Lys816 (Shimshon et al., 2011; Ying et al., 2012). This modification is
catalyzed by the E3 SUMO-protein ligase PIAS1 and has been shown to mediate
opposite effects based on the context: on one hand sumoylation is reported to facilitate
BLIMP-1’s proteolytic degradation, and on the other hand, it promotes BLIMP-1
dependent transcriptional repression during B cell maturation (Shimshon et al., 2011;
Ying et al., 2012). How and whether BLIMP-1 sumoylation affects the hypoxiadependent BLIMP-1 action remains to be elucidated. Notably, the affected Lys residue
is not conserved in nematodes, indicating that another Lys or another yet unidentified
type of BLMP-1 modification might contribute to the regulation of BLMP-1 function and
stability in C. elegans (Tunyaplin et al., 2000).

As already initiated in this study, one could screen all known mediators of the oxygen
response using available RNAi libraries by looking at loss of 3kb-F45D3.4:GFP levels
as a readout. Alternatively, considering that HIF-1 acetylation in hypoxia increases its
stability, one can test a panel of acetylase and deacetylase RNAi libraries for their
potential to modify the BLMP-1 dependent GFP induction of F45D3.4:GFP in hypoxia. I
found that hda-1 could potentially mediate the HIF-independent hypoxia response,
although it will be necessary to expand the screen.

RNAi-based screens have some limitations such as targeting only coding sequences
and incomplete knockdown rates resulting in many false negatives. In a more unbiased
approach one could perform EMS mutagenesis in 3kb-F45D3.4::GFP reporters in the
hif-1 mutant background that were treated with hypoxia and look for lack of GFP
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induction (Jorgensen and Mango, 2002). In such a screen one would expect to find
mutations in blmp-1 and other unknown modulators of the HIF-independent response,
including lin-40 or perhaps other recently discovered regulators like dre-1. dre-1
encodes a C. elegans F-box protein that functions in an SCF E3-ubiquitin ligase
complex. DRE-1 promotes BLMP-1 ubiquitination to coordinate developmental
progression through L3. I generated dre-1(RNAi) worms to check if the knockdown of
dre-1 would modify 3kb-F45D3.4:GFP expression in hypoxia. Although the 3kbF45D3.4:GFP readout in hypoxia was not altered with dre-1 knockdown, it may be
important to evaluate the regulation of BLMP-1 at L3. dre-1::GFP is not expressed in the
adult stages of the worm, and my screen was limited to the adult stages.
It will be particularly interesting to find an upstream regulator of the HIF-independent
hypoxia response that also acts as an oxygen sensor. Owing to their ability to regulate
HIF-1, prolyl hydroxylases have been considered to be oxygen sensors. Since egl-9
mutation does not alter 3kb-F45D3.4::GFP expression, it is likely that egl-9 does not
function as a sensor for the HIF-independent response. In C. elegans, changes in
oxygen concentration are sensed by guanylate cyclases (GCs) gcy-31, 33 or 35, that
reside in either BAG or URX/AQR/PQR. URX, AQR and PQR neurons respond to
oxygen shifts above the physiologic range and BAG neurons respond to oxygen shifts
below the physiologic range. It is likely that a GC residing in one of these neurons,
particularly gcy-31 that resides in the BAG neurons, acts as the oxygen sensor that
mediates the HIF-independent response. Indeed, RNAi knockdown of gcy-31 resulted in
a 48% reduction in 3kb-F45D3.4:GFP levels (Figure 4.12). Knockdown of gyc-33 and
gcy-35 did not modify the GFP readout. Only genes whose knockdown resulted in at
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least 75% reduction in 3kb-F45D3.4:GFP levels were considered positive hits in my
screen, so gcy-31 was not considered a positive hit. Nevertheless, it will be interesting
to explore the role of gcy-31 in the HIF-independent hypoxia response.

5.7. BLMP-1 and ER stress
A cell undergoing hypoxia must curtail oxygen consumption by energy expensive
processes like protein synthesis. Through the lack of oxygen acting as the terminal
electron acceptor in the redox reaction for disulphide bond formation, hypoxia impairs
protein folding in the ER. The accumulation of unfolded proteins within the ER activates
the Unfolded Protein Response (UPR), which mediates a global reduction in
transcription and translation through IRE-1-XBP-1, PERK-eIF2A-ATF4, and ATF6
signaling pathways (X. Shen et al., 2001). UPR is activated by several stress conditions
like starvation and pathogenesis (Richardson, Kinkel, & Kim, 2011). Importantly, the
UPR is an important mediator of the hypoxia microenvironment and it functions
independently of HIF-1 (Wouters & Koritzinsky, 2008). Given that BLMP-1 mediates the
transcriptional response in hypoxia, including that of an HSP70 protein F44E5.5, I
wondered if BLMP-1 contributes to the UPR response to promote hypoxia tolerance.

I focused on the IRE-1-XBP-1 pathway that is conserved from yeast to mammals (Cox
& Walter, 1996; X. Shen et al., 2001; Yoshida, Matsui, Yamamoto, Okada, & Mori,
2001). Upon accumulation of unfolded proteins in the ER, IRE-1, an integral ERmembrane protein, activates XBP-1 by alternative splicing of the xbp-1 mRNA, thereby
changing the reading frame. The activated ‘spliced form’ of XBP-1 regulates expression
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of genes involved in ER homeostasis, such as those encoding chaperones including
heat shock proteins. In C.elegans, The IRE-1 and XBP-1 pathway has been studied
with respect to aging (D. Chen et al., 2009), hypoxic preconditioning (Mao & Crowder,
2010) and larval development and immunity (Richardson et al., 2011).

The marked increase in the hsp-4::GFP transgene and expression levels of hsp-4
mRNA and spliced xbp-1 in hypoxia with the loss of blmp-1 suggests that BLMP-1
functions in the IRE-1-XBP-1 pathway of UPR. To establish if BLMP-1 based hsp4::GFP induction reflects canonical IRE-1-XBP-1 UPR signaling, it would be important
to investigate if concurrent loss of xbp-1 abrogates the blmp-1 dependent increase in
hypoxia (Calfon et al., 2002).

The sensitivity of blmp-1 mutants to ER stressing agent tunicamycin suggests that
BLMP-1 plays a protective role in hypoxia by limiting damage by UPR in hypoxia.
Indeed prolonged or unresolved ER stress activates pro-apoptotic genes including
CHOP/GADD153 to induce cell death (Rao, Ellerby, & Bredesen, 2004). To make any
conclusive statements regarding BLMP-1’s role in hypoxia, however, it will be important
to test how the other UPR sensors, PERK-eIF2-ATF4 and ATF-6, contribute to BLMP-1
dependent hypoxia protection. For instance, the phosphorylation levels of eukaryotic
translation initiation factor eIF2α could be tested in blmp-1 mutants treated to hypoxia
(Ron & Walter, 2007). If BLMP-1 indeed protects the cell from hypoxia stress, loss of
BLMP-1 should show marked increases in eIF2α phosphorylation in hypoxia, which
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would indicate an inability to shut down global protein synthesis. (Mao & Crowder,
2010).

The idea that BLMP-1 could contribute to UPR is intriguing, given mammalian BLIMP1’s role in B cell differentiation (Shaffer et al., 2004). BLIMP-1 is essential in the
differentiation of quiescent B cells to plasma cells allowing them to become antibody
producing cells, a process that is also mediated by components of the UPR, in particular
XBP-1 (Yanjun and Hendershot, 2003). Moreover, a microarray study showed that
mammalian BLMP-1 regulates a host of stress proteins, including hsp70 and ERresident processing genes. BLIMP-1 has not been observed in the ER in normoxia, but
does it translocate to the ER to mediate IRE-1 dependent xbp-1 splicing in hypoxia?
Does the loss of BLIMP-1 and prolonged hypoxia distort ER morphology in hypoxia?
(Rao et al., 2004). Further studies exploring the role of BLMP-1 hypoxia mediated UPR
are warranted.

5.8. BLMP-1 and collagen
Of the genes induced in hypoxia, several were involved in collagen synthesis and
molting; Collagens and extracellular matrix proteins were found to be induced in hypoxia
(C. Shen et al., 2005). Moreover, embryos mutant for phy-2, a prolyl 4-hydroxylase
involved in collagen formation, were unable to survive hypoxia treatment (C. Shen et al.,
2005). Interestingly, a recent ChIP-seq study for targets of BLMP-1 in C. elegans,
showed that BLMP-1 bound to the promoters of collagen formation genes, including
HIF-independent genes bli-3 and ptr-8 (Horn et al., 2014). I found that bli-3 and ptr-8
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were regulated in a BLMP-1 dependent, but HIF-1 independent manner in hypoxia.
Moreover, bli3-/- mutants were sensitive to hypoxia treatment, in a manner similar to
that of blmp-1 mutants. Taken together, these data strongly suggest that BLMP-1
targets a set of molting and cuticle-related genes in C.elegans, consistent with a general
role in the molt cycle and the synthesis of the adult cuticle. However, the relation
between collagen formation and hypoxia has not been well explored. Interestingly, in
mammals, hypoxia treatment increases the expression of prolyl-4-hydroxylases.
Exposure of human dermal fibroblasts to hypoxia for 72 hours led to a threefold, dosedependent increase in collagenous protein (Falanga, Zhou, & Yufit, 2002). My results
open up some interesting questions regarding hypoxia and collagen formation. Why is
hypoxia important for collagen formation? Is the ER stress phenotype of BLMP-1 related
to its role in collagen synthesis? It will be interesting to explore the answers to these
questions in the future.
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6. Significance
The work presented in this thesis has helped uncover novel regulators of a hypoxiasensitive pathway that works independent of HIF-1 in C. elegans. Through a targeted
RNAi approach, I isolated a novel transcription factor and a chromatin remodeling factor
that mediate the hypoxia response in C.elegans. Given the high similarity between the
worm and human counterparts of both these entities, this study presents some exciting
avenues for future research in the field of hypoxia. Moreover, I also identified some very
interesting upstream regulators, including histone deacetylase 1 and oxygen sensor
guanylyl cyclase, gcy-31, as potential regulators of the HIF-independent hypoxia
response. Additionally, the robust HIF-independent hypoxia reporter 3kb-F45D3.4:GFP
can be used to screen for non-transcription factor regulators. I am very excited at the
future possibilities from this work.
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7. CPT1: A short story in lipid oxidation
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Introduction:
In limiting nutrition conditions, the oxidative degradation of free fatty acids (FAs)
liberates stored energy for ATP production. Several pathologies occur owing to
mutations in key steps in lipid oxidation pathways. Some of these pathologies can be
managed through diet; for example, carnitine palmitoyltransferase deficiency, in which
the body cannot utilize fat owing to a deficiency in the CPT1 enzyme, can be managed
through diet. For several other disorders, for instance, in Refsum disease or X-linked
adrenoleukodystrophy, treatment options are not available.
Although lipid oxidation can proceed through several cellular pathways, the preferred
route for fatty acids is through mitochondrial β-oxidation (mβ-ox), which occurs in the
mitochondrial matrix. To enter the matrix, LCFAs must first be activated by CoA-ligation,
which is then exchanged for carnitine in the inner membrane space. Hence, carnitine
conjugation permits access to the matrix. This reaction is catalyzed We sought to
determine the extent by the enzyme carnitine palmitoyltransferase I or CPT1. Since
lipids are primarily stored in a long-chain form, the carnitine shuttle is an important
regulatory barrier for most available FAs. In the absence of a working carnitine shuttle,
as happens with CPTI mutation, LCFAs can be shortened by peroxisomal β-oxidation
(pβ-ox). Though not capable of complete oxidation, pβ-ox truncates a variety of FAs to
lengths that can enter the matrix without the need for carnitine, including dihydroxy
acids (DHAs) and very (V) LCFAs, which must be metabolized in the peroxisome.
Whereas VLCFAs are directly accepted by peroxisomes, LCFAs first require
hydroxylation at the ω- or α-carbon in the endoplasmic reticulum (ER). Thus, α- and ω-
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oxidation of LCFAs, coupled with pβ-ox, can be vital alternate routes for animals that
cannot rely on the preferred route of FA oxidation (termed alt-ox animals).
We aimed to use Drosophila melanogaster as a model to investigate the oxidation of
LCFAs. This system is genetically tractable and has a wealth of tools available with
which to study the conserved regulatory aspects of metabolism in the context of an
intact animal. As in mammals, flies rely on LCFA burn during starvation. In fact, adult
emergence in Drosophila depends on metamorphic oxidation of LCFAs that are stored
during the larval state (Palanker et al. 2010). Our previous studies had established that
Estrogen-Related Receptor (dERR) mutants rely on alternative lipid oxidation pathways
upon metamorphic-induced starvation for survival (Li et al., 2013). We sought to
determine the extent to which alternative routes of lipid oxidation can be used as a
rescue when the preferred route is unavailable. For this, we decided to use Drosophila
cpt-1-/- null mutants that lack the ability to oxidize lipids through the conventional fatty
acid pathway.
Despite carnitine shuttle elimination, CPTI mutants survive to adulthood and are longlived, indicating that they successfully employ the alternate lipid oxidation strategy.
Surprisingly, 13 different alleles of CPTI have demonstrated that it is not an essential
gene, despite it having the confirmed activity of a mitochondrial carnitine
palmitoyltransferase (Strub et al., 2008). Given the central nature of CPTI in LCFA
metabolism and the fact that there are not redundant paralogs in Drosophila, it is
remarkable that the cpt-1-/- mutants are healthy; they show mild phenotypes like
withering of the wings and mild sensitivities to oxidative stress, starvation, and heavy
metals (Strub et al., 2008). These attributes make the viable cpt-1-/- null mutant the ideal
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candidate to study alt-ox pathways. We decided to examine this by determining the
basal lipid metabolite and transcriptional profiles of animals reared on a standard diet

To handle the increased load of alternative LCFA metabolites, we reasoned that
transcripts encoding alt-ox enzymes will be correspondingly upregulated. Figure 1
describes the LCFA oxidation pathway. FA2H catalyzes the first step in α-oxidation,
while CYP4s3 does for ω-oxidation. Both CYP4s3 and FA2H act directly on free LCFAs
and are thought to be rate limiting for ω- and α-oxidation, respectively. Both of these
alternative pathways converge in peroxisomes where peroxisome-specific ACS
proteins, like the putative peroxisomal dicarboxylyl-CoA synthase CG6178, activate the
ω-and α-oxidation metabolites, thus allowing for pβ-ox to truncate the LC lipids to
shorter forms. The shorter form FAs eventually leave the peroxisome and gain entrance
into the mitochondria, bypassing the carnitine shuttle altogether, where they are
oxidized to completion by chain length-specific enzymes, including MCAD and SCAD.
Finally, Cyp6a8, a hydroxylase that putatively acts on the (ω -1)-carbon of FAs, may
allow for pβ-ox access for (ω -1)-modified LCFAs.
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Aims:
In this short study, we hypothesized that enzymes mediating the alternative oxidation
will be misregulated in cpt-1-/- mutants and we were interested in knowing which of the
pathways, ω- and α-oxidation, is preferentially used by these mutants to circumvent the
block in LCFA oxidation. Additionally, we aimed to conduct a metabolic profile of the
cpt-1-/- mutants to establish an altered lipid profile for these mutants.

LCFA metabolism can proceed in a carnitine
shuttle-independent manner through the
oxidation pathways that converge in the
peroxisome before moving into the
mitochondria
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Methods:
qRT-PCR analysis:
Total RNA samples were isolated using a TRIzol/RQ1 DNase hybrid extraction protocol
(Promega, Madison, WI). RNA was reverse transcribed with the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA) using the manufacturer's
specifications. For real-time PCR, premixed primer-probe sets were purchased from
Applied Biosystems. All amplifications were carried out on a CFX96 real-time PCR
system (Bio-Rad, Hercules, CA). Experimental values were normalized to values
obtained for the Rp49 probe set. Data are reported as the mean±SEM. All values
reported represent experiments performed on at least three biological replicates.
Sample collection for mass spectrometric analysis:
Sample preparation:
Wild type and CPT1 mutant flies of the white prepupa stage were washed thoroughly in
PBS and frozen at -80C. After thawing the larvae were homogenized in 3 ml of 2:1 of
methanol: chloroform in an all-glass homogenizer using an ‘A’ or ‘tight’ pestle. The
sample was then centrifuged, the pellet washed once with the same solvent, and the
wash was combined with the first extract. Mass matched triplicate samples were
collected and the solvent evaporated in vacuum. The residue was taken up in 100ul
methanol and 5 ul of this solution was injected for HPLC-MS analysis.
Mass spectrometric analysis:
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HPLC-MS profiling was performed using the Agilent 1100 Series HPLC system
equipped with an Agilent Eclipse XDB-C18 column (4.6 X 250 mm, 5 um particle
diameter) connected to the Waters/Micromass Quattro Ultima triple-quad mass
spectrometer using a 1:1 split. Chromatographic separation was performed with two
different gradients. First, 0.1% acetic acid in water (solvent A) and acetonitrile (solvent
B). Second, 0.1 % acetic acid in acetonitrile (A) and propanol-2 (solvent B). The first
gradient was used for untargeted analysis of entire larvae metabolomes, while the
second gradient for used for targeted analysis of fatty acids. In both cases the flow rate
was 1 ml/min and the gradient started with 5% B for 5 min followed by a linear gradient
from 5 to 100% B from 5 to 37 min. 100% B was then held for 8 min after which the
column was reconditioned with 5% B for the next run.
Metabolic extracts were analyzed by HPLC-ESI-MS in a negative ion mode using a
capillary voltage of 3.5 kV and a cone voltage of -60 V.
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Results:
1) Gene expression analysis
We looked at the expression of few enzymes of the alternative oxidation pathway.
These included: FA2H (Enzyme catalyzing the first step in α-oxidation); CYP4s3
(Enzyme catalyzing the first step in ω-oxidation); CG6178: Putative peroxisomal
dicarboxylyl-CoA synthase that catalyzes the activation of ω-oxidation and α-oxidation
metabolites to allow for peroxisomal beta oxidation; and Cyp6a8 (putative hydroxylase
that acts on the (ω -1)-carbon of fatty acids). Interestingly, we saw a marked increase in
fa2h levels in the cpt-1-/- mutants, suggesting a marked increase in α-oxidation.
Conversely, the levels of CYP4s3 and CG6178 was markedly reduced. These results
suggests that the cpt-1-/- mutants undertake alternative oxidation pathways, possibly αoxidation, to utilize different lipids to bypass a block in LCFA burn in the mitochondria.
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Figure 2: Alternative lipid oxidation pathway are altered in the cpt-1-/- mutant qRTqRT-PCR results show that the expression of key enzymes in the alternative lipid
oxidation pathway are misregulated in the mutant. *p<0.05. **p<0.01. Data are
expressed as mean ± SEM
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2) Metabolic analysis
The identity of each of the unknown metabolites was then queried via the Metlin
repository comprising the masses and structures of known metabolites (Smith et al.,
2005). Most of the unknown metabolites identified by my study could not be identified
using the Metlin database, which is not surprising considering the database is not
exhaustive and is not Drosophila specific. However, two of the unknown masses
revealed potentially interesting results.
The unknown metabolite with m/z 160 with retention time of 11.2 min that was
significantly up in the cpt-1-/- mutant might be as L-carnitine Formula: C7H15NO3.
Although several further studies are needed to confirm this, the increase in carnitine
levels in the cpt-1-/- mutant provides reasonable validation to the importance of the
data. The unknown metabolite with m/z 442 was identified as guanosine 5′-diphosphate
(GDP) and that at mass 362 was identified as guanosine 3'-phosphate. Additionally,
owing to the same retention time of 3.57 min and difference in masses of one sodium
atom (22), the metabolite with m/z 447 is likely related to the metabolite with m/z 469.
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Table 1: Unknown metabolites from mass spectrometric analysis
Metabolites that
were increased in
the cpt-1-/- mutant
[M-H]m/z

Retention time

Fold induction

Standard error

(mins)
437

7.11

116

±1.71

447

3.57

18

±2.99

160

11.12

16

±4.47

561

11.15

11

±2.16

469

3.57

8

±0.83

390

24.99

6

±0.48

Retention time

Fold reduction

Standard error

Metabolites that
were decreased in
the cpt-1-/- mutant
[M-H]m/z

(mins)
442

34.7

67

±5.59

344

34.7

49

±5.52

424

2.8

19

±3.75

308

2.7

15

1.45

342

34.34

10

1.29

175

2.73

9

±1.33

362

3.47

6

±0.27

357

8.95

6

0.24

155

18.49

5

0.09
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Discussion and Future Directions:
This is the first study that has attempted to understand alternative lipid oxidation
pathways. We conducted our study in Drosophila cpt1-/- mutants that are unable to
oxidize fat in the conventional beta oxidation pathway, but yet, are relatively healthy.
Our analysis of differences in the expression of key enzymes of the alt-oxidation
pathway revealed interesting results. Our data suggests that cpt-1-/- mutants are able to
route lipid oxidation to alternative pathways, and that it is likely that this alternative
pathway allows them to survive even when the default pathway is inactive. We see
marked upregulation of fa2h in cpt-/- mutants, which suggests that α-oxidation alone is
sufficient for the succeeding steps in the peroxisome and that it is bypasses ωoxidation. This brings up further interesting questions regarding cpt-1-/- mutants: How do
they perform under starvation? Does diet promote or deter the effectiveness of the
rescue?
We had previously used the services of the company Metabolon to conduct mass
spectrometric analysis for us. To save on costs, we attempted to develop our own inhouse protocol for conducting mass spectrometric analysis. We successfully generated
extracts from pre-pupa larvae and were able to identify fifteen misregulated metabolites
between the wild type and cpt-1-/- mutant.
One potential metabolite isolated is carnitine (m/z 160). Although the increase in
carnitine levels in the cpt-1-/- mutant is plausible, several further studies are warranted.
First, we need to compare the peak obtained from our fly extract with that generated by
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a carnitine standard in order to verify the identity of our peak. Unfortunately, we were
unable to find a cheap commercially available standard to compare our results with.
Further, to confirm the elemental composition of the identified compounds, the
metabolite masses can be obtained by high resolution LC/MS. Additional structural
information can be derived from fragmentation analysis by MS/MS. For the unknown
metabolites, NMR spectroscopic studies may be conducted.
To our knowledge, this is a first study of its kind and we hope this short story is a
foundation for future experiments exploring alternative fatty acid oxidation pathways.
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